{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:54:49Z","timestamp":1792572889984,"version":"4.5.0"},"reference-count":280,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["320030-204978"],"award-info":[{"award-number":["320030-204978"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006447","name":"University of Zurich","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006447","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The potent hallucinogen\n                    <jats:italic>N,N-<\/jats:italic>\n                    dimethyltryptamine (DMT) has garnered significant interest in recent years due to its profound effects on consciousness and its therapeutic psychopotential. DMT is an integral (but not exclusive) psychoactive alkaloid in the Amazonian plant-based brew ayahuasca, in which admixture of several\n                    <jats:italic>\u03b2<\/jats:italic>\n                    -carboline monoamine oxidase A (MAO-A) inhibitors potentiate the activity of oral DMT, while possibly contributing in other respects to the complex psychopharmacology of ayahuasca. Irrespective of the route of administration, DMT alters perception, mood, and cognition, presumably through agonism at serotonin (5-HT) 1A\/2A\/2C receptors in brain, with additional actions at other receptor types possibly contributing to its overall psychoactive effects. Due to rapid first pass metabolism, DMT is nearly inactive orally, but co-administration with\n                    <jats:italic>\u03b2<\/jats:italic>\n                    -carbolines or synthetic MAO-A inhibitors (MAOIs) greatly increase its bioavailability and duration of action. The synergistic effects of DMT and MAOIs in ayahuasca or synthetic formulations may promote neuroplasticity, which presumably underlies their promising therapeutic efficacy in clinical trials for neuropsychiatric disorders, including depression, addiction, and post-traumatic stress disorder. Advances in neuroimaging techniques are elucidating the neural correlates of DMT-induced altered states of consciousness, revealing alterations in brain activity, functional connectivity, and network dynamics. In this comprehensive narrative review, we present a synthesis of current knowledge on the pharmacology and neuroscience of DMT,\n                    <jats:italic>\u03b2<\/jats:italic>\n                    -carbolines, and ayahuasca, which should inform future research aiming to harness their full therapeutic potential.\n                  <\/jats:p>","DOI":"10.1007\/s00018-024-05353-6","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T02:02:32Z","timestamp":1725933752000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors"],"prefix":"10.1007","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5072-9674","authenticated-orcid":false,"given":"Klemens","family":"Egger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5915-7086","authenticated-orcid":false,"given":"Helena D.","family":"Aicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0257-9621","authenticated-orcid":false,"given":"Paul","family":"Cumming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1313-2208","authenticated-orcid":false,"given":"Milan","family":"Scheidegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,10]]},"reference":[{"key":"5353_CR1","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1124\/pr.115.011478","volume":"68","author":"DE Nichols","year":"2016","unstructured":"Nichols DE (2016) Psychedelics. Pharmacol Rev 68:264\u2013355. https:\/\/doi.org\/10.1124\/pr.115.011478","journal-title":"Pharmacol Rev"},{"key":"5353_CR2","volume-title":"PIHKAL, a chemical love story","author":"AT Shulgin","year":"1991","unstructured":"Shulgin AT, Shulgin A (1991) PIHKAL, a chemical love story. Transform Press, Berkeley"},{"key":"5353_CR3","volume-title":"TIHKAL, the continuation","author":"AT Shulgin","year":"1997","unstructured":"Shulgin AT, Shulgin A (1997) TIHKAL, the continuation. Transform Press"},{"key":"5353_CR4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/J.NRLENG.2011.07.010","volume":"30","author":"FJ Carod-Artal","year":"2015","unstructured":"Carod-Artal FJ (2015) Hallucinogenic drugs in pre-Columbian Mesoamerican cultures. Neurolog\u00eda (English Edition) 30:42\u201349. https:\/\/doi.org\/10.1016\/J.NRLENG.2011.07.010","journal-title":"Neurolog\u00eda (English Edition)"},{"key":"5353_CR5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s002130000606","volume":"154","author":"J Riba","year":"2001","unstructured":"Riba J, Rodr\u00edguez-Fornells A, Urbano G et al (2001) Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers. Psychopharmacology 154:85\u201395. https:\/\/doi.org\/10.1007\/s002130000606","journal-title":"Psychopharmacology"},{"key":"5353_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/dta.1685","volume":"7","author":"J Riba","year":"2015","unstructured":"Riba J, McIlhenny EH, Bouso JC, Barker SA (2015) Metabolism and urinary disposition of N, N-dimethyltryptamine after oral and smoked administration: a comparative study. Drug Test Anal  7:401\u2013406. https:\/\/doi.org\/10.1002\/dta.1685","journal-title":"Drug Test Anal"},{"key":"5353_CR7","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41398-023-02477-4","volume":"13","author":"SB Vogt","year":"2023","unstructured":"Vogt SB, Ley L, Erne L et al (2023) Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants. Transl Psychiatry 13:172. https:\/\/doi.org\/10.1038\/s41398-023-02477-4","journal-title":"Transl Psychiatry"},{"key":"5353_CR8","doi-asserted-by":"publisher","DOI":"10.1177\/02698811231196877","author":"LX Luan","year":"2023","unstructured":"Luan LX, Eckern\u00e4s E, Ashton M et al (2023) Psychological and physiological effects of extended DMT. J Psychopharmacol. https:\/\/doi.org\/10.1177\/02698811231196877","journal-title":"J Psychopharmacol"},{"key":"5353_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/02791072.1979.10472092","volume":"11","author":"A Hofmann","year":"1979","unstructured":"Hofmann A (1979) How LSD originated. J Psychedelic Drugs 11:53\u201360. https:\/\/doi.org\/10.1080\/02791072.1979.10472092","journal-title":"J Psychedelic Drugs"},{"key":"5353_CR10","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/s0378-8741(98)00168-8","volume":"65","author":"JC Callaway","year":"1999","unstructured":"Callaway JC, McKenna DJ, Grob CS et al (1999) Pharmacokinetics of Hoasca alkaloids in healthy humans. J Ethnopharmacol 65:243\u2013256. https:\/\/doi.org\/10.1016\/s0378-8741(98)00168-8","journal-title":"J Ethnopharmacol"},{"key":"5353_CR11","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/00005053-199602000-00004","volume":"184","author":"CS Grob","year":"1996","unstructured":"Grob CS, McKenna DJ, Callaway JC et al (1996) Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil. J Nervous Mental Dis 184:86\u201394. https:\/\/doi.org\/10.1097\/00005053-199602000-00004","journal-title":"J Nervous Mental Dis"},{"key":"5353_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/02791072.2005.10399801","volume":"37","author":"PCR Barbosa","year":"2005","unstructured":"Barbosa PCR, Giglio JS, Dalgalarrondo P (2005) Altered states of consciousness and short-term psychological after-effects induced by the first time ritual use of ayahuasca in an urban context in Brazil. J Psychoactive Drugs 37:193\u2013201. https:\/\/doi.org\/10.1080\/02791072.2005.10399801","journal-title":"J Psychoactive Drugs"},{"key":"5353_CR13","volume-title":"Ayahuasca visions: the religious iconography of a Peruvian Shaman","author":"LE Luna","year":"1999","unstructured":"Luna LE, Amaringo P (1999) Ayahuasca visions: the religious iconography of a Peruvian Shaman. North Atlantic Books, Berkely"},{"key":"5353_CR14","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.psychres.2018.04.012","volume":"264","author":"A Franquesa","year":"2018","unstructured":"Franquesa A, Sainz-Cort A, Gandy S et al (2018) Psychological variables implied in the therapeutic effect of ayahuasca: a contextual approach. Psychiatry Res 264:334\u2013339. https:\/\/doi.org\/10.1016\/j.psychres.2018.04.012","journal-title":"Psychiatry Res"},{"key":"5353_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-3-642-40426-9_4","volume-title":"The therapeutic use of ayahuasca","author":"B Shanon","year":"2014","unstructured":"Shanon B (2014) Moments of insight, healing, and transformation: a cognitive phenomenological analysis. In: Labate BC, Cavnar C (eds) The therapeutic use of ayahuasca. Springer, Berlin, pp 59\u201375"},{"key":"5353_CR16","first-page":"125","volume":"24","author":"B Shanon","year":"2003","unstructured":"Shanon B (2003) Altered states and the study of consciousness\u2014the case of ayahuasca. J Mind Behav 24:125\u2013153","journal-title":"J Mind Behav"},{"key":"5353_CR17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/02791072.2015.1094590","volume":"47","author":"V Kavensk\u00e1","year":"2015","unstructured":"Kavensk\u00e1 V, Simonov\u00e1 H (2015) Ayahuasca tourism: participants in shamanic rituals and their personality styles, motivation, benefits and risks. J Psychoactive Drugs 47:351\u2013359. https:\/\/doi.org\/10.1080\/02791072.2015.1094590","journal-title":"J Psychoactive Drugs"},{"key":"5353_CR18","first-page":"5","volume":"13","author":"T Bresnick","year":"2006","unstructured":"Bresnick T, Levin R (2006) Phenomenal qualities of ayahuasca ingestion and its relation to fringe consciousness and personality. J Conscious Stud 13:5\u201324","journal-title":"J Conscious Stud"},{"key":"5353_CR19","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/02791072.2009.10399767","volume":"41","author":"A Kjellgren","year":"2009","unstructured":"Kjellgren A, Eriksson A, Norlander T (2009) Experiences of encounters with ayahuasca\u2014\u201cthe vine of the soul.\u201d J Psychoactive Drugs 41:309\u2013315. https:\/\/doi.org\/10.1080\/02791072.2009.10399767","journal-title":"J Psychoactive Drugs"},{"key":"5353_CR20","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1055\/a-1675-3840","volume":"88","author":"M Politi","year":"2022","unstructured":"Politi M, Tresca G, Menghini L, Ferrante C (2022) Beyond the psychoactive effects of ayahuasca: cultural and pharmacological relevance of its emetic and purging properties. Planta Med 88:1275\u20131286. https:\/\/doi.org\/10.1055\/a-1675-3840","journal-title":"Planta Med"},{"key":"5353_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/acprof:oso\/9780199341191.001.0001","volume-title":"Ayahuasca shamanism in the Amazon and beyond","author":"BC Labate","year":"2014","unstructured":"Labate BC, Cavnar C (2014) Ayahuasca shamanism in the Amazon and beyond. Oxford University Press, New York"},{"key":"5353_CR22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1556-3537.2012.01056.x","volume":"23","author":"BT Anderson","year":"2012","unstructured":"Anderson BT (2012) Ayahuasca as antidepressant? Psychedelics and styles of reasoning in psychiatry. Anthropol Conscious 23:44\u201359. https:\/\/doi.org\/10.1111\/j.1556-3537.2012.01056.x","journal-title":"Anthropol Conscious"},{"key":"5353_CR23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/02791072.2009.10400530","volume":"41","author":"PC Barbosa","year":"2009","unstructured":"Barbosa PC, Cazorla IM, Giglio JS, Strassman R (2009) A six-month prospective evaluation of personality traits, psychiatric symptoms and quality of life in ayahuasca-naive subjects. J Psychoactive Drugs 41:205\u2013212. https:\/\/doi.org\/10.1080\/02791072.2009.10400530","journal-title":"J Psychoactive Drugs"},{"key":"5353_CR24","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.brainresbull.2009.09.008","volume":"81","author":"JJ Fortunato","year":"2010","unstructured":"Fortunato JJ, R\u00e9us GZ, Kirsch TR et al (2010) Effects of \u03b2-carboline harmine on behavioral and physiological parameters observed in the chronic mild stress model: further evidence of antidepressant properties. Brain Res Bull 81:491\u2013496. https:\/\/doi.org\/10.1016\/j.brainresbull.2009.09.008","journal-title":"Brain Res Bull"},{"key":"5353_CR25","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s00702-010-0451-2","volume":"117","author":"JJ Fortunato","year":"2010","unstructured":"Fortunato JJ, R\u00e9us GZ, Kirsch TR et al (2010) Chronic administration of harmine elicits antidepressant-like effects and increases BDNF levels in rat hippocampus. J Neural Transm 117:1131\u20131137. https:\/\/doi.org\/10.1007\/s00702-010-0451-2","journal-title":"J Neural Transm"},{"key":"5353_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.687615","author":"SGD Ruffell","year":"2021","unstructured":"Ruffell SGD, Netzband N, Tsang W et al (2021) Ceremonial ayahuasca in amazonian retreats\u2014mental health and epigenetic outcomes from a six-month naturalistic study. Front Psychiatry. https:\/\/doi.org\/10.3389\/fpsyt.2021.687615","journal-title":"Front Psychiatry"},{"key":"5353_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadr.2021.100098","volume":"4","author":"J Sarris","year":"2021","unstructured":"Sarris J, Perkins D, Cribb L et al (2021) Ayahuasca use and reported effects on depression and anxiety symptoms: an international cross-sectional study of 11,912 consumers. J Affect Disord Rep 4:100098. https:\/\/doi.org\/10.1016\/j.jadr.2021.100098","journal-title":"J Affect Disord Rep"},{"key":"5353_CR28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1590\/1516-4446-2014-1496","volume":"37","author":"FL de Os\u00f3rio","year":"2015","unstructured":"de Os\u00f3rio FL, Sanches RF, Macedo LR et al (2015) Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report. Braz J Psychiatry 37:13\u201320. https:\/\/doi.org\/10.1590\/1516-4446-2014-1496","journal-title":"Braz J Psychiatry"},{"key":"5353_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/JCP.0000000000000436","volume":"36","author":"RF Sanches","year":"2016","unstructured":"Sanches RF, de Lima OF, Dos Santos RG et al (2016) Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a SPECT study. J Clin Psychopharmacol 36:77\u201381. https:\/\/doi.org\/10.1097\/JCP.0000000000000436","journal-title":"J Clin Psychopharmacol"},{"key":"5353_CR30","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1017\/S0033291718001356","volume":"49","author":"F Palhano-Fontes","year":"2019","unstructured":"Palhano-Fontes F, Barreto D, Onias H et al (2019) Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial. Psychol Med 49:655\u2013663. https:\/\/doi.org\/10.1017\/S0033291718001356","journal-title":"Psychol Med"},{"key":"5353_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2807","author":"E Dom\u00ednguez-Clav\u00e9","year":"2022","unstructured":"Dom\u00ednguez-Clav\u00e9 E, Soler J, Elices M et al (2022) Ayahuasca may help to improve self-compassion and self-criticism capacities. Human Psychopharmacol. https:\/\/doi.org\/10.1002\/hup.2807","journal-title":"Human Psychopharmacol"},{"key":"5353_CR32","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1007\/s00213-021-06046-9","volume":"239","author":"K van Oorsouw","year":"2022","unstructured":"van Oorsouw K, Toennes SW, Ramaekers JG (2022) Therapeutic effect of an ayahuasca analogue in clinically depressed patients: a longitudinal observational study. Psychopharmacology 239:1839\u20131852. https:\/\/doi.org\/10.1007\/s00213-021-06046-9","journal-title":"Psychopharmacology"},{"key":"5353_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01325","author":"RJ Zeifman","year":"2019","unstructured":"Zeifman RJ, Palhano-Fontes F, Hallak J et al (2019) The impact of ayahuasca on suicidality: results from a randomized controlled trial. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2019.01325","journal-title":"Front Pharmacol"},{"key":"5353_CR34","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2174\/15733998113099990003","volume":"6","author":"G Thomas","year":"2013","unstructured":"Thomas G, Lucas P, Capler N et al (2013) Ayahuasca-assisted therapy for addiction: results from a preliminary observational study in Canada. Curr Drug Abuse Rev 6:30\u201342. https:\/\/doi.org\/10.2174\/15733998113099990003","journal-title":"Curr Drug Abuse Rev"},{"key":"5353_CR35","doi-asserted-by":"publisher","first-page":"204512532098663","DOI":"10.1177\/2045125320986634","volume":"11","author":"DM O\u2019Shaughnessy","year":"2021","unstructured":"O\u2019Shaughnessy DM, Berlowitz I, Rodd R et al (2021) Within-treatment changes in a novel addiction treatment program using traditional Amazonian medicine. Ther Adv Psychopharmacol 11:204512532098663. https:\/\/doi.org\/10.1177\/2045125320986634","journal-title":"Ther Adv Psychopharmacol"},{"key":"5353_CR36","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1080\/02791072.2019.1607956","volume":"51","author":"I Berlowitz","year":"2019","unstructured":"Berlowitz I, Walt H, Ghasarian C et al (2019) Short-term treatment effects of a substance use disorder therapy involving traditional Amazonian medicine. J Psychoactive Drugs 51:323\u2013334. https:\/\/doi.org\/10.1080\/02791072.2019.1607956","journal-title":"J Psychoactive Drugs"},{"key":"5353_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2018.00136","author":"PCR Barbosa","year":"2018","unstructured":"Barbosa PCR, T\u00f3foli LF, Bogenschutz MP et al (2018) Assessment of alcohol and tobacco use  disorders among religious users of ayahuasca. Front Psychiatry. https:\/\/doi.org\/10.3389\/fpsyt.2018.00136","journal-title":"Front Psychiatry"},{"key":"5353_CR38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/02791072.2013.873157","volume":"46","author":"A Loizaga-Velder","year":"2014","unstructured":"Loizaga-Velder A, Verres R (2014) Therapeutic effects of ritual ayahuasca use in the treatment of substance dependence\u2014qualitative results. J Psychoactive Drugs 46:63\u201372. https:\/\/doi.org\/10.1080\/02791072.2013.873157","journal-title":"J Psychoactive Drugs"},{"key":"5353_CR39","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s40519-018-0619-6","volume":"25","author":"M Renelli","year":"2020","unstructured":"Renelli M, Fletcher J, Tupper KW et al (2020) An exploratory study of experiences with conventional eating disorder treatment and ceremonial ayahuasca for the healing of eating disorders. Eat Weight Disord 25:437\u2013444. https:\/\/doi.org\/10.1007\/s40519-018-0619-6","journal-title":"Eat Weight Disord"},{"key":"5353_CR40","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/02791072.2017.1361559","volume":"49","author":"A Lafrance","year":"2017","unstructured":"Lafrance A, Loizaga-Velder A, Fletcher J et al (2017) Nourishing the spirit: exploratory research on ayahuasca experiences along the continuum of recovery from eating disorders. J Psychoactive Drugs 49:427\u2013435. https:\/\/doi.org\/10.1080\/02791072.2017.1361559","journal-title":"J Psychoactive Drugs"},{"key":"5353_CR41","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1177\/0030222817710879","volume":"79","author":"D Gonz\u00e1lez","year":"2019","unstructured":"Gonz\u00e1lez D, Carvalho M, Cantillo J et al (2019) Potential use of ayahuasca in grief therapy. Omega 79:260\u2013285. https:\/\/doi.org\/10.1177\/0030222817710879","journal-title":"Omega"},{"key":"5353_CR42","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s00213-019-05446-2","volume":"237","author":"D Gonz\u00e1lez","year":"2020","unstructured":"Gonz\u00e1lez D, Cantillo J, P\u00e9rez I et al (2020) Therapeutic potential of ayahuasca in grief: a prospective, observational study. Psychopharmacology 237:1171\u20131182. https:\/\/doi.org\/10.1007\/s00213-019-05446-2","journal-title":"Psychopharmacology"},{"key":"5353_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118143","volume":"10","author":"F Palhano-Fontes","year":"2015","unstructured":"Palhano-Fontes F, Andrade KC, Tofoli LF et al (2015) The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network. PLoS\u00a0One 10:e0118143. https:\/\/doi.org\/10.1371\/journal.pone.0118143","journal-title":"PLoS\u00a0One"},{"key":"5353_CR44","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.2727","volume":"4","author":"V Dakic","year":"2016","unstructured":"Dakic V, de Maciel RM, Drummond H, et al (2016) Harmine stimulates proliferation of human neural progenitors. PeerJ 4:e2727. https:\/\/doi.org\/10.7717\/peerj.2727","journal-title":"PeerJ"},{"key":"5353_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.112743","volume":"255","author":"A Katchborian-Neto","year":"2020","unstructured":"Katchborian-Neto A, Santos WT, Nic\u00e1cio KJ et al (2020) Neuroprotective potential of ayahuasca and untargeted metabolomics analyses: applicability to Parkinson\u2019s disease. J Ethnopharmacol 255:112743. https:\/\/doi.org\/10.1016\/j.jep.2020.112743","journal-title":"J Ethnopharmacol"},{"key":"5353_CR46","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.euroneuro.2022.10.008","volume":"66","author":"LO Maia","year":"2023","unstructured":"Maia LO, Daldegan-Bueno D, Wie\u00dfner I et al (2023) Ayahuasca\u2019s therapeutic potential: What we know \u2013 and what not. Eur Neuropsychopharmacol 66:45\u201361. https:\/\/doi.org\/10.1016\/j.euroneuro.2022.10.008","journal-title":"Eur Neuropsychopharmacol"},{"key":"5353_CR47","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1590\/1516-4446-2015-1701","volume":"38","author":"RG Dos Santos","year":"2016","unstructured":"Dos Santos RG, Osorio FL, Crippa JA, Hallak JE (2016) Antidepressive and anxiolytic effects of ayahuasca: a systematic literature review of animal and human studies. Braz J Psychiatry 38:65\u201372. https:\/\/doi.org\/10.1590\/1516-4446-2015-1701","journal-title":"Braz J Psychiatry"},{"key":"5353_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.623979","author":"D Perkins","year":"2021","unstructured":"Perkins D, Schubert V, Simonov\u00e1 H et al (2021) Influence of context and setting on the mental health and wellbeing outcomes of ayahuasca drinkers: results of a large international survey. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2021.623979","journal-title":"Front Pharmacol"},{"key":"5353_CR49","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1360-0443.2006.01652.x","volume":"102","author":"RS Gable","year":"2007","unstructured":"Gable RS (2007) Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids. Addiction 102:24\u201334. https:\/\/doi.org\/10.1111\/j.1360-0443.2006.01652.x","journal-title":"Addiction"},{"key":"5353_CR50","doi-asserted-by":"publisher","first-page":"12307","DOI":"10.1021\/acsomega.2c00795","volume":"7","author":"L Rodr\u00edguez","year":"2022","unstructured":"Rodr\u00edguez L, L\u00f3pez A, Moyna G et al (2022) New insights into the chemical composition of ayahuasca. ACS Omega 7:12307\u201312317. https:\/\/doi.org\/10.1021\/acsomega.2c00795","journal-title":"ACS Omega"},{"key":"5353_CR51","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s13659-019-0210-5","volume":"9","author":"EA Estrella-Parra","year":"2019","unstructured":"Estrella-Parra EA, Almanza-P\u00e9rez JC, Alarc\u00f3n-Aguilar FJ (2019) Ayahuasca: uses, phytochemical and biological activities. Nat Prod Bioprospect 9:251\u2013265. https:\/\/doi.org\/10.1007\/s13659-019-0210-5","journal-title":"Nat Prod Bioprospect"},{"key":"5353_CR52","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0378-8741(84)90003-5","volume":"10","author":"DJ McKenna","year":"1984","unstructured":"McKenna DJ, Towers GH, Abbott F (1984) Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca. J Ethnopharmacol 10:195\u2013223. https:\/\/doi.org\/10.1016\/0378-8741(84)90003-5","journal-title":"J Ethnopharmacol"},{"key":"5353_CR53","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/02791072.2020.1815911","volume":"53","author":"H Kaasik","year":"2021","unstructured":"Kaasik H, Souza RCZ, Zandonadi FS et al (2021) Chemical composition of traditional and analog ayahuasca. J Psychoactive Drugs 53:65\u201375. https:\/\/doi.org\/10.1080\/02791072.2020.1815911","journal-title":"J Psychoactive Drugs"},{"key":"5353_CR54","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1080\/02791072.2020.1820641","volume":"53","author":"M Politi","year":"2021","unstructured":"Politi M, Friso F, Saucedo G, Torres J (2021) Traditional Use of Banisteriopsis caapi alone and its application in a context of drug addiction therapy. J Psychoactive Drugs 53:76\u201384. https:\/\/doi.org\/10.1080\/02791072.2020.1820641","journal-title":"J Psychoactive Drugs"},{"key":"5353_CR55","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/02791072.2008.10400645","volume":"40","author":"R Rodd","year":"2008","unstructured":"Rodd R (2008) Reassessing the cultural and psychopharmacological significance of Banisteriopsis caapi: preparation, classification and use among the Piaroa of Southern Venezuela. J Psychoactive Drugs 40:301\u2013307. https:\/\/doi.org\/10.1080\/02791072.2008.10400645","journal-title":"J Psychoactive Drugs"},{"key":"5353_CR56","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/02791072.1999.10471741","volume":"31","author":"J Ott","year":"1999","unstructured":"Ott J (1999) Pharmahuasca: human pharmacology of oral DMT plus harmine. J Psychoactive Drugs 31:171\u2013177. https:\/\/doi.org\/10.1080\/02791072.1999.10471741","journal-title":"J Psychoactive Drugs"},{"key":"5353_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/J.JEP.2021.114910","volume":"286","author":"I Berlowitz","year":"2022","unstructured":"Berlowitz I, O\u2019Shaughnessy DM, Heinrich M et al (2022) Teacher plants\u2014Indigenous Peruvian-Amazonian dietary practices as a method for using psychoactives. J Ethnopharmacol 286:114910. https:\/\/doi.org\/10.1016\/J.JEP.2021.114910","journal-title":"J Ethnopharmacol"},{"key":"5353_CR58","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.jep.2010.02.013","volume":"128","author":"Y-H Wang","year":"2010","unstructured":"Wang Y-H, Samoylenko V, Tekwani BL et al (2010) Composition, standardization and chemical profiling of Banisteriopsis caapi, a plant for the treatment of neurodegenerative disorders relevant to Parkinson\u2019s disease. J Ethnopharmacol 128:662\u2013671. https:\/\/doi.org\/10.1016\/j.jep.2010.02.013","journal-title":"J Ethnopharmacol"},{"key":"5353_CR59","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/s0376-8716(98)00154-9","volume":"54","author":"CS Freedland","year":"1999","unstructured":"Freedland CS, Mansbach RS (1999) Behavioral profile of constituents in ayahuasca, an Amazonian psychoactive plant mixture. Drug Alcohol Depend 54:183\u2013194. https:\/\/doi.org\/10.1016\/s0376-8716(98)00154-9","journal-title":"Drug Alcohol Depend"},{"key":"5353_CR60","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3389\/fnins.2018.00536","volume":"12","author":"SA Barker","year":"2018","unstructured":"Barker SA (2018) N,N-dimethyltryptamine (DMT), an endogenous hallucinogen: past, present, and future research to determine its role and function. Front Neurosci 12:536. https:\/\/doi.org\/10.3389\/fnins.2018.00536","journal-title":"Front Neurosci"},{"key":"5353_CR61","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1124\/jpet.103.049882","volume":"306","author":"J Riba","year":"2003","unstructured":"Riba J, Valle M, Urbano G et al (2003) Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics. J Pharmacol Exp Ther 306:73\u201383. https:\/\/doi.org\/10.1124\/jpet.103.049882","journal-title":"J Pharmacol Exp Ther"},{"key":"5353_CR62","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s00213-011-2434-x","volume":"219","author":"RG Dos Santos","year":"2012","unstructured":"Dos Santos RG, Grasa E, Valle M et al (2012) Pharmacology of ayahuasca administered in two repeated doses. Psychopharmacology 219:1039\u20131053. https:\/\/doi.org\/10.1007\/s00213-011-2434-x","journal-title":"Psychopharmacology"},{"key":"5353_CR63","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/978-3-642-40426-9_2","volume-title":"The therapeutic use of ayahuasca","author":"F Palhano-Fontes","year":"2014","unstructured":"Palhano-Fontes F, Alchieri JC, Oliveira JPM et al (2014) The therapeutic potentials of ayahuasca in the treatment of depression. In: Labate BC, Cavnar C (eds) The therapeutic use of ayahuasca. Springer, Berlin, pp 23\u201339"},{"key":"5353_CR64","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1016\/0024-3205(77)90190-4","volume":"20","author":"NS Buckholtz","year":"1977","unstructured":"Buckholtz NS, Boggan WO (1977) Inhibition by \u03b2-carbolines of monoamine uptake into a synaptosomal preparation: structure-activity relationships. Life Sci 20:2093\u20132100. https:\/\/doi.org\/10.1016\/0024-3205(77)90190-4","journal-title":"Life Sci"},{"key":"5353_CR65","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.bbrc.2004.11.033","volume":"326","author":"T Herraiz","year":"2005","unstructured":"Herraiz T, Chaparro C (2005) Human monoamine oxidase is inhibited by tobacco smoke: \u03b2-carboline alkaloids act as potent and reversible inhibitors. Biochem Biophys Res Commun 326:378\u2013386. https:\/\/doi.org\/10.1016\/j.bbrc.2004.11.033","journal-title":"Biochem Biophys Res Commun"},{"key":"5353_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27134297","author":"ND Chaurasiya","year":"2022","unstructured":"Chaurasiya ND, Leon F, Muhammad I, Tekwani BL (2022) Natural products inhibitors of monoamine  oxidases-potential new drug leads for neuroprotection, neurological disorders, and neuroblastoma. Molecules. https:\/\/doi.org\/10.3390\/molecules27134297","journal-title":"Molecules"},{"key":"5353_CR67","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0014-2999(98)00392-6","volume":"353","author":"S Ben-Shabat","year":"1998","unstructured":"Ben-Shabat S, Fride E, Sheskin T et al (1998) An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. Eur J Pharmacol 353:23\u201331. https:\/\/doi.org\/10.1016\/S0014-2999(98)00392-6","journal-title":"Eur J Pharmacol"},{"key":"5353_CR68","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.brainresbull.2016.03.002","volume":"126","author":"E Dominguez-Clave","year":"2016","unstructured":"Dominguez-Clave E, Soler J, Elices M et al (2016) Ayahuasca: pharmacology, neuroscience and therapeutic potential. Brain Res Bull 126:89\u2013101. https:\/\/doi.org\/10.1016\/j.brainresbull.2016.03.002","journal-title":"Brain Res Bull"},{"key":"5353_CR69","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.pharmathera.2004.03.002","volume":"102","author":"DJ McKenna","year":"2004","unstructured":"McKenna DJ (2004) Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges. Pharmacol Ther 102:111\u2013129. https:\/\/doi.org\/10.1016\/j.pharmathera.2004.03.002","journal-title":"Pharmacol Ther"},{"key":"5353_CR70","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3390\/plants9070870","volume":"9","author":"BWL Santos","year":"2020","unstructured":"Santos BWL, de Oliveira RC, Sonsin-Oliveira J et al (2020) Biodiversity of \u03b2-carboline profile of Banisteriopsis caapi and ayahuasca, a plant and a brew with Neuropharmacological potential. Plants 9:870. https:\/\/doi.org\/10.3390\/plants9070870","journal-title":"Plants"},{"key":"5353_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25092072","author":"G de Oliveira Silveira","year":"2020","unstructured":"de Oliveira Silveira G, Guimar\u00e3es Dos Santos R, Rebello Louren\u00e7o F et al (2020) Stability evaluation of DMT and harmala alkaloids in ayahuasca tea samples. Molecules. https:\/\/doi.org\/10.3390\/molecules25092072","journal-title":"Molecules"},{"key":"5353_CR72","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/BF02860772","volume":"26","author":"L Rivier","year":"1972","unstructured":"Rivier L, Lindgren J-E (1972) \u201cAyahuasca\u201d, the South American hallucinogenic drink: an ethnobotanical and chemical investigation. Econ Bot 26:101\u2013129. https:\/\/doi.org\/10.1007\/BF02860772","journal-title":"Econ Bot"},{"key":"5353_CR73","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1080\/02791072.2005.10399796","volume":"37","author":"JC Callaway","year":"2005","unstructured":"Callaway JC (2005) Various alkaloid profiles in decoctions of Banisteriopsis caapi. J Psychoactive Drugs 37:151\u2013155. https:\/\/doi.org\/10.1080\/02791072.2005.10399796","journal-title":"J Psychoactive Drugs"},{"key":"5353_CR74","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/pca.1110","volume":"20","author":"APS Pires","year":"2009","unstructured":"Pires APS, De Oliveira CDR, Moura S et al (2009) Gas chromatographic analysis of dimethyltryptamine and \u03b2-carboline alkaloids in ayahuasca, an amazonian psychoactive plant beverage. Phytochem Anal 20:149\u2013153. https:\/\/doi.org\/10.1002\/pca.1110","journal-title":"Phytochem Anal"},{"key":"5353_CR75","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jchromb.2019.06.014","volume":"1124","author":"RCZ Souza","year":"2019","unstructured":"Souza RCZ, Zandonadi FS, Freitas DP et al (2019) Validation of an analytical method for the determination of the main ayahuasca active compounds and application to real ayahuasca samples from Brazil. J Chromatogr B 1124:197\u2013203. https:\/\/doi.org\/10.1016\/j.jchromb.2019.06.014","journal-title":"J Chromatogr B"},{"key":"5353_CR76","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1080\/02791072.2015.1013202","volume":"47","author":"R Lanaro","year":"2015","unstructured":"Lanaro R, CalemiTogni DBALR et al (2015) Ritualistic use of ayahuasca versus street use of similar substances seized by the police: a key factor involved in the potential for intoxications and overdose? J Psychoactive Drugs 47:132\u2013139. https:\/\/doi.org\/10.1080\/02791072.2015.1013202","journal-title":"J Psychoactive Drugs"},{"key":"5353_CR77","volume-title":"Pharmacotheon: entheogenic drugs, their plant sources and history","author":"J Ott","year":"1993","unstructured":"Ott J (1993) Pharmacotheon: entheogenic drugs, their plant sources and history. Natural Products Co., Kennewick"},{"key":"5353_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2018.01297","author":"Q Huang","year":"2018","unstructured":"Huang Q, Li L, Zheng M et al (2018) The tryptophan decarboxylase 1 gene from Aegilops variabilis no. 1 regulate the resistance against cereal cyst nematode by altering the downstream secondary metabolite contents rather than auxin synthesis. Front Plant Sci. https:\/\/doi.org\/10.3389\/fpls.2018.01297","journal-title":"Front Plant Sci"},{"key":"5353_CR79","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1023\/A:1022983529555","volume":"29","author":"RIS Gill","year":"2003","unstructured":"Gill RIS, Ellis BE, Isman MB (2003) Tryptamine-induced resistance in tryptophan decarboxylase transgenic poplar and tobacco plants against their specific herbivores. J Chem Ecol 29:779\u2013793. https:\/\/doi.org\/10.1023\/A:1022983529555","journal-title":"J Chem Ecol"},{"key":"5353_CR80","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1556\/2054.2019.013","volume":"3","author":"M Clark","year":"2019","unstructured":"Clark M (2019) Soma and Haoma: Ayahuasca analogues from the late bronze age. J Psychedelic Stud 3:104\u2013116. https:\/\/doi.org\/10.1556\/2054.2019.013","journal-title":"J Psychedelic Stud"},{"key":"5353_CR81","doi-asserted-by":"publisher","first-page":"199","DOI":"10.4103\/0973-7847.120524","volume":"7","author":"M Moloudizargari","year":"2013","unstructured":"Moloudizargari M, Mikaili P, Aghajanshakeri S et al (2013) Pharmacological and therapeutic effects of Peganum harmala and its main alkaloids. Pharmacogn Rev 7:199. https:\/\/doi.org\/10.4103\/0973-7847.120524","journal-title":"Pharmacogn Rev"},{"key":"5353_CR82","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/s0254-6272(15)30016-9","volume":"35","author":"CN Mina","year":"2015","unstructured":"Mina CN, Farzaei MH, Gholamreza A (2015) Medicinal properties of Peganum harmala L. in traditional Iranian medicine and modern phytotherapy: a review. J Tradit Chin Med 35:104\u2013109. https:\/\/doi.org\/10.1016\/s0254-6272(15)30016-9","journal-title":"J Tradit Chin Med"},{"key":"5353_CR83","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1080\/10508619.2023.2185369","volume":"33","author":"R Savoldi","year":"2023","unstructured":"Savoldi R, Roazzi A, de Oliveira Sales RC (2023) Mystical and ego-dissolution experiences in Ayahuasca and Jurema holistic rituals: an exploratory study. Int J Psychol Relig 33:332\u2013360. https:\/\/doi.org\/10.1080\/10508619.2023.2185369","journal-title":"Int J Psychol Relig"},{"key":"5353_CR84","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1590\/S1516-89132008000500010","volume":"51","author":"RSO de Souza","year":"2008","unstructured":"de Souza RSO, de Albuquerque UP, Monteiro JM, de Amorim ELC (2008) Jurema-Preta (Mimosa tenuiflora [Willd.] Poir.): a review of its traditional use, phytochemistry and pharmacology. Braz Arch Biol Technol 51:937\u2013947. https:\/\/doi.org\/10.1590\/S1516-89132008000500010","journal-title":"Braz Arch Biol Technol"},{"key":"5353_CR85","volume-title":"The healing journey: new approaches to consciousness","author":"C Naranjo","year":"1974","unstructured":"Naranjo C (1974) The healing journey: new approaches to consciousness, 1st edn. Pantheon Books, New York","edition":"1"},{"key":"5353_CR86","volume-title":"Ayahuasca Analogues: Pang\u00e6an Entheogens","author":"J Ott","year":"1994","unstructured":"Ott J (1994) Ayahuasca Analogues: Pang\u00e6an Entheogens. Natural Products  Company"},{"key":"5353_CR87","first-page":"143","volume-title":"The world ayahuasca diaspora","author":"G St John","year":"2016","unstructured":"St John G (2016) Aussiewaska: a cultural history of changa and ayahuasca analogues in Australia. In: Labate BC, Cavnar C, Gearin AK (eds) The world ayahuasca diaspora. Taylor & Francis Group, Routledge, pp 143\u2013162"},{"key":"5353_CR88","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1111\/1365-2664.14488","volume":"60","author":"MA Coe","year":"2023","unstructured":"Coe MA, Gaoue OG (2023) Increased clonal growth in heavily harvested ecosystems failed to rescue ayahuasca lianas from decline in the Peruvian Amazon rainforest. J Appl Ecol 60:2105\u20132117. https:\/\/doi.org\/10.1111\/1365-2664.14488","journal-title":"J Appl Ecol"},{"key":"5353_CR89","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1246892","author":"DA Dornbierer","year":"2023","unstructured":"Dornbierer DA, Marten L, Mueller J et al (2023) Overcoming the clinical challenges of traditional ayahuasca: a first-in-human trial exploring novel routes of administration of N,N-dimethyltryptamine and harmine. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2023.1246892","journal-title":"Front Pharmacol"},{"key":"5353_CR90","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1126\/science.134.3475.343","volume":"134","author":"J Axelrod","year":"1961","unstructured":"Axelrod J (1961) Enzymatic formation of psychotomimetic metabolites from normally occurring compounds. Science 134:343\u2013343. https:\/\/doi.org\/10.1126\/science.134.3475.343","journal-title":"Science"},{"key":"5353_CR91","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1006\/geno.1999.5960","volume":"61","author":"MA Thompson","year":"1999","unstructured":"Thompson MA, Moon E, Kim UJ et al (1999) Human indolethylamine N-methyltransferase: cDNA cloning and expression, gene cloning, and chromosomal localization. Genomics 61:285\u2013297. https:\/\/doi.org\/10.1006\/geno.1999.5960","journal-title":"Genomics"},{"key":"5353_CR92","doi-asserted-by":"publisher","first-page":"9333","DOI":"10.1038\/s41598-019-45812-w","volume":"9","author":"JG Dean","year":"2019","unstructured":"Dean JG, Liu T, Huff S et al (2019) Biosynthesis and extracellular concentrations of N,N-dimethyltryptamine (DMT) in mammalian brain. Sci Rep 9:9333. https:\/\/doi.org\/10.1038\/s41598-019-45812-w","journal-title":"Sci Rep"},{"key":"5353_CR93","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41598-023-27538-y","volume":"13","author":"NG Glynos","year":"2023","unstructured":"Glynos NG, Carter L, Lee SJ et al (2023) Indolethylamine N-methyltransferase (INMT) is not essential for endogenous tryptamine-dependent methylation activity in rats. Sci Rep 13:280. https:\/\/doi.org\/10.1038\/s41598-023-27538-y","journal-title":"Sci Rep"},{"key":"5353_CR94","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.neubiorev.2009.04.003","volume":"33","author":"PJ Fitzgerald","year":"2009","unstructured":"Fitzgerald PJ (2009) Neuromodulating mice and men: Are there functional species differences in neurotransmitter concentration? Neurosci Biobehav Rev 33:1037\u20131041. https:\/\/doi.org\/10.1016\/j.neubiorev.2009.04.003","journal-title":"Neurosci Biobehav Rev"},{"key":"5353_CR95","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1140656","author":"K Egger","year":"2023","unstructured":"Egger K, Gudmundsen F, Jessen NS et al (2023) A pilot study of cerebral metabolism and serotonin 5-HT2A receptor occupancy in rats treated with the psychedelic tryptamine DMT in conjunction with the MAO inhibitor harmine. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2023.1140656","journal-title":"Front Pharmacol"},{"key":"5353_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2020.113615","volume":"191","author":"T K\u00f6rm\u00f6czi","year":"2020","unstructured":"K\u00f6rm\u00f6czi T, Szab\u00f3 \u00cd, Farkas E et al (2020) Heart-cutting two-dimensional liquid chromatography coupled to quadrupole-orbitrap high resolution mass spectrometry for determination of N,N-dimethyltryptamine in rat plasma and brain; Method development and application. J Pharm Biomed Anal 191:113615. \nhttps:\/\/doi.org\/10.1016\/j.jpba.2020.113615","journal-title":"J Pharm Biomed Anal"},{"key":"5353_CR97","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1007\/s00213-022-06065-0","volume":"239","author":"SA Barker","year":"2022","unstructured":"Barker SA (2022) Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT. Psychopharmacology 239:1749\u20131763. https:\/\/doi.org\/10.1007\/s00213-022-06065-0","journal-title":"Psychopharmacology"},{"key":"5353_CR98","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1021\/acschemneuro.8b00101","volume":"9","author":"LP Cameron","year":"2018","unstructured":"Cameron LP, Olson DE (2018) Dark classics in chemical neuroscience: N,N-dimethyltryptamine (DMT). ACS Chem Neurosci 9:2344\u20132357. https:\/\/doi.org\/10.1021\/acschemneuro.8b00101","journal-title":"ACS Chem Neurosci"},{"key":"5353_CR99","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/0006-2952(72)90119-0","volume":"21","author":"I Cohen","year":"1972","unstructured":"Cohen I, Vogel WH (1972) Determination and physiological disposition of dimethyltryptamine and diethyltryptamine in rat brain, liver and plasma. Biochem Pharmacol 21:1214\u20131216. https:\/\/doi.org\/10.1016\/0006-2952(72)90119-0","journal-title":"Biochem Pharmacol"},{"key":"5353_CR100","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/0006-2952(87)90118-3","volume":"36","author":"BR Sitaram","year":"1987","unstructured":"Sitaram BR, Lockett L, Talomsin R et al (1987) In vivo metabolism of 5-methoxy-N,N-dimethyltryptamine and N,N-dimethyltryptamine in the rat. Biochem Pharmacol 36:1509\u20131512. https:\/\/doi.org\/10.1016\/0006-2952(87)90118-3","journal-title":"Biochem Pharmacol"},{"key":"5353_CR101","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/BF00276707","volume":"12","author":"K Yanai","year":"1986","unstructured":"Yanai K, Ido T, Ishiwata K et al (1986) In vivo kinetics and displacement study of a carbon-11-labeled hallucinogen, N,N-[11C]dimethyltryptamine. Eur J Nucl Med 12:141\u2013146. https:\/\/doi.org\/10.1007\/BF00276707","journal-title":"Eur J Nucl Med"},{"key":"5353_CR102","doi-asserted-by":"publisher","first-page":"970","DOI":"10.2967\/JNUMED.110.083246","volume":"52","author":"AA Vitale","year":"2011","unstructured":"Vitale AA, Pomilio AB, Ca\u00f1ellas CO et al (2011) In vivo long-term kinetics of radiolabeled N,N-dimethyltryptamine and tryptamine. J Nucl Med 52:970\u2013977. https:\/\/doi.org\/10.2967\/JNUMED.110.083246","journal-title":"J Nucl Med"},{"key":"5353_CR103","doi-asserted-by":"publisher","first-page":"1140656","DOI":"10.3389\/fphar.2023.1140656","volume":"14","author":"K Egger","year":"2023","unstructured":"Egger K, Gudmundsen F, Jessen NS et al (2023) A pilot study of cerebral metabolism and serotonin 5-HT2A receptor occupancy in rats treated with the psychedelic tryptamine DMT in conjunction with the MAO inhibitor harmine. Front Pharmacol 14:1140656. https:\/\/doi.org\/10.3389\/fphar.2023.1140656","journal-title":"Front Pharmacol"},{"key":"5353_CR104","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s00702-013-1024-y","volume":"120","author":"E Frecska","year":"2013","unstructured":"Frecska E, Szabo A, Winkelman MJ et al (2013) A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity. J Neural Transm (Vienna) 120:1295\u20131303. https:\/\/doi.org\/10.1007\/s00702-013-1024-y","journal-title":"J Neural Transm (Vienna)"},{"key":"5353_CR105","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23115954","author":"RI Teleanu","year":"2022","unstructured":"Teleanu RI, Niculescu A-G, Roza E et al (2022) Neurotransmitters-key factors in neurological and neurodegenerative disorders of the central nervous system. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23115954","journal-title":"Int J Mol Sci"},{"key":"5353_CR106","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1177\/02698811221104054","volume":"36","author":"JH Jim\u00e9nez","year":"2022","unstructured":"Jim\u00e9nez JH, Bouso JC (2022) Significance of mammalian N,N-dimethyltryptamine (DMT): a 60-year-old debate. J Psychopharmacol 36:905\u2013919. https:\/\/doi.org\/10.1177\/02698811221104054","journal-title":"J Psychopharmacol"},{"key":"5353_CR107","doi-asserted-by":"publisher","DOI":"10.3390\/ph13110334","author":"AM Brito-da-Costa","year":"2020","unstructured":"Brito-da-Costa AM, Dias-da-Silva D, Gomes NGM et al (2020) Toxicokinetics and toxicodynamics of ayahuasca alkaloids N,N-dimethyltryptamine (DMT), harmine, harmaline and tetrahydroharmine: clinical and forensic impact. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/ph13110334","journal-title":"Pharmaceuticals (Basel)"},{"key":"5353_CR108","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/dta.1344","volume":"4","author":"J Riba","year":"2012","unstructured":"Riba J, McIlhenny EH, Valle M et al (2012) Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca. Drug Test Anal 4:610\u2013616. https:\/\/doi.org\/10.1002\/dta.1344","journal-title":"Drug Test Anal"},{"key":"5353_CR109","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/dta.2197","volume":"10","author":"AT Caspar","year":"2018","unstructured":"Caspar AT, Gaab JB, Michely JA et al (2018) Metabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine studied by GC-MS, LC-MS n, and LC-HR-MS\/MS. Drug Test Anal 10:184\u2013195. https:\/\/doi.org\/10.1002\/dta.2197","journal-title":"Drug Test Anal"},{"key":"5353_CR110","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s13318-023-00822-y","volume":"48","author":"M Good","year":"2023","unstructured":"Good M, Joel Z, Benway T et al (2023) Pharmacokinetics of N,N-dimethyltryptamine in humans. Eur J Drug Metab Pharmacokinet 48:311\u2013327. https:\/\/doi.org\/10.1007\/s13318-023-00822-y","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"5353_CR111","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.886408","author":"I Berlowitz","year":"2022","unstructured":"Berlowitz I, Egger K, Cumming P (2022) Monoamine oxidase inhibition by plant-derived \u03b2-carbolines; Implications for the psychopharmacology of tobacco and ayahuasca. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.886408","journal-title":"Front Pharmacol"},{"key":"5353_CR112","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.2174\/0929867043364757","volume":"11","author":"JC Shih","year":"2004","unstructured":"Shih JC, Chen K (2004) Regulation of MAO-A and MAO-B gene expression. Curr Med Chem 11:1995\u20132005. https:\/\/doi.org\/10.2174\/0929867043364757","journal-title":"Curr Med Chem"},{"key":"5353_CR113","first-page":"365","volume":"187","author":"HY Yang","year":"1973","unstructured":"Yang HY, Neff NH (1973) Beta-phenylethylamine: a specific substrate for type B monoamine oxidase of brain. J Pharmacol Exp Ther 187:365\u2013371","journal-title":"J Pharmacol Exp Ther"},{"key":"5353_CR114","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1111\/j.1471-4159.1981.tb10829.x","volume":"36","author":"DD Schoepp","year":"1981","unstructured":"Schoepp DD, Azzaro AJ (1981) Specificity of endogenous substrates for types A and B monoamine oxidase in rat striatum. J Neurochem 36:2025\u20132031. https:\/\/doi.org\/10.1111\/j.1471-4159.1981.tb10829.x","journal-title":"J Neurochem"},{"key":"5353_CR115","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/glia.440080208","volume":"8","author":"J Ekblom","year":"1993","unstructured":"Ekblom J, Jossan SS, Bergstr\u00f6m M et al (1993) Monoamine oxidase-B in astrocytes. Glia 8:122\u2013132. https:\/\/doi.org\/10.1002\/glia.440080208","journal-title":"Glia"},{"key":"5353_CR116","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511575853","volume-title":"Imaging dopamine","author":"P Cumming","year":"2009","unstructured":"Cumming P (2009) Imaging dopamine. Cambridge University Press, Cambridge"},{"key":"5353_CR117","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.1021\/acschemneuro.3c00591","volume":"14","author":"GR Hoffman","year":"2023","unstructured":"Hoffman GR, Olson MG, Schoffstall AM et al (2023) Classics in chemical neuroscience: selegiline, isocarboxazid, phenelzine, and tranylcypromine. ACS Chem Neurosci 14:4064\u20134075. https:\/\/doi.org\/10.1021\/acschemneuro.3c00591","journal-title":"ACS Chem Neurosci"},{"key":"5353_CR118","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.4088\/JCP.08m05041blu","volume":"70","author":"KI Shulman","year":"2009","unstructured":"Shulman KI, Fischer HD, Herrmann N et al (2009) Current prescription patterns and safety profile of irreversible monoamine oxidase inhibitors. J Clin Psychiatry 70:1681\u20131686. https:\/\/doi.org\/10.4088\/JCP.08m05041blu","journal-title":"J Clin Psychiatry"},{"key":"5353_CR119","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0091-3057(78)90070-9","volume":"8","author":"NS Shah","year":"1978","unstructured":"Shah NS, Hedden MP (1978) Behavioral effects and metabolic fate of N,N-dimethyltryptamine in mice pretreated with beta-diethylaminoethyl-diphenylpropylacetate (SKF 525-A), improniazid and chlorpromazine. Pharmacol Biochem Behav 8:351\u2013356. https:\/\/doi.org\/10.1016\/0091-3057(78)90070-9","journal-title":"Pharmacol Biochem Behav"},{"key":"5353_CR120","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/BF00432184","volume":"75","author":"A Morinan","year":"1981","unstructured":"Morinan A, Collier JG (1981) Effects of pargyline and SKF-525A on brain N,N-dimethyltryptamine concentrations and hyperactivity in mice. Psychopharmacology 75:179\u2013183. https:\/\/doi.org\/10.1007\/BF00432184","journal-title":"Psychopharmacology"},{"key":"5353_CR121","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/J.BEPROC.2015.05.004","volume":"118","author":"A Pic-Taylor","year":"2015","unstructured":"Pic-Taylor A, da Motta LG, de Morais JA et al (2015) Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rat. Behav Proc 118:102\u2013110. https:\/\/doi.org\/10.1016\/J.BEPROC.2015.05.004","journal-title":"Behav Proc"},{"key":"5353_CR122","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1590\/1516-4446-2020-0913","volume":"43","author":"\u00cd Durante","year":"2021","unstructured":"Durante \u00cd, Dos Santos RG, Bouso JC, Hallak JE (2021) Risk assessment of ayahuasca use in a religious context: self-reported risk factors and adverse effects. Braz J Psychiatry 43:362\u2013369. https:\/\/doi.org\/10.1590\/1516-4446-2020-0913","journal-title":"Braz J Psychiatry"},{"key":"5353_CR123","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.drugalcdep.2010.03.024","volume":"111","author":"JM F\u00e1bregas","year":"2010","unstructured":"F\u00e1bregas JM, Gonz\u00e1lez D, Fondevila S et al (2010) Assessment of addiction severity among ritual users of ayahuasca. Drug Alcohol Depend 111:257\u2013261. https:\/\/doi.org\/10.1016\/j.drugalcdep.2010.03.024","journal-title":"Drug Alcohol Depend"},{"key":"5353_CR124","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0000438","volume":"2","author":"JC Bouso","year":"2022","unstructured":"Bouso JC, Andi\u00f3n \u00d3, Sarris JJ et al (2022) Adverse effects of ayahuasca: results from the global ayahuasca survey. PLOS Global Public Health 2:e0000438. https:\/\/doi.org\/10.1371\/journal.pgph.0000438","journal-title":"PLOS Global Public Health"},{"key":"5353_CR125","first-page":"Sr15","volume":"14","author":"JH Halpern","year":"2008","unstructured":"Halpern JH, Sherwood AR, Passie T et al (2008) Evidence of health and safety in American members of a religion who use a hallucinogenic sacrament. Med Sci Monit 14:Sr15\u2013Sr22","journal-title":"Med Sci Monit"},{"key":"5353_CR126","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s13181-016-0593-1","volume":"13","author":"CW Heise","year":"2017","unstructured":"Heise CW, Brooks DE (2017) Ayahuasca exposure: descriptive analysis of calls to US poison control centers from 2005 to 2015. J Med Toxicol 13:245\u2013248. https:\/\/doi.org\/10.1007\/s13181-016-0593-1","journal-title":"J Med Toxicol"},{"key":"5353_CR127","unstructured":"Su\u00e1rez \u00c1lvarez C, Mazarrasa J, Bouso JC et al (2023) Ayahuasca global consumption & reported deaths. In: ICEERS, Excutive Summary, https:\/\/www.iceers.org\/ayahuasca-global-consumption-deaths\/"},{"key":"5353_CR128","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1177\/0004867412462749","volume":"47","author":"JM Warren","year":"2013","unstructured":"Warren JM, Dham-Nayyar P, Alexander J (2013) Recreational use of naturally occurring dimethyltryptamine\u2014contributing to psychosis? Aust N Z J Psychiatry 47:398\u2013399. https:\/\/doi.org\/10.1177\/0004867412462749","journal-title":"Aust N Z J Psychiatry"},{"key":"5353_CR129","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1556-3537.2008.00006.x","volume":"19","author":"SE Lewis","year":"2008","unstructured":"Lewis SE (2008) Ayahuasca and spiritual crisis: liminality as space for personal growth. Anthropol Conscious 19:109\u2013133. https:\/\/doi.org\/10.1111\/j.1556-3537.2008.00006.x","journal-title":"Anthropol Conscious"},{"key":"5353_CR130","doi-asserted-by":"publisher","DOI":"10.4324\/9781315538501","volume-title":"Ayahuasca, ritual and religion in Brazil","author":"BC Labate","year":"2016","unstructured":"Labate BC, MacRae E (2016) Ayahuasca, ritual and religion in Brazil. Routledge"},{"key":"5353_CR131","unstructured":"Londo\u00f1o D, Mazarrasa J, Aixal\u00e0 MB et al (2019) Towards better ayahuasca practices. A guide for organizers and participants. In: ICEERS, new guide: towards better ayahuasca practices. https:\/\/www.iceers.org\/launch-of-the-guide-towards-better-ayahuasca-practices\/"},{"key":"5353_CR132","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/BF02157378","volume":"12","author":"S Sz\u00e1ra","year":"1956","unstructured":"Sz\u00e1ra S (1956) Dimethyltryptamin: its metabolism in man; the relation to its psychotic effect to the serotonin metabolism. Experientia 12:441\u2013442. https:\/\/doi.org\/10.1007\/BF02157378","journal-title":"Experientia"},{"key":"5353_CR133","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/BF00367455","volume":"223","author":"A Dittrich","year":"1976","unstructured":"Dittrich A, Bickel P, Sch\u00f6pf J, Zimmer D (1976) Comparison of altered states of consciousness induced by the hallucinogens (\u2013)-delta9-trans-tetrahydrocannabinol (delta9-THC) and N, N-dimethyltryptamine (DMT) (author\u2019s transl). Arch Psychiatr Nervenkr 223:77\u201387. https:\/\/doi.org\/10.1007\/BF00367455","journal-title":"Arch Psychiatr Nervenkr"},{"key":"5353_CR134","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1055\/s-0028-1094495","volume":"9","author":"P Bickel","year":"1976","unstructured":"Bickel P, Dittrich A, Schoepf J (1976) Altered states of consciousness induced by N, N-dimethyltryptamine (DMT). Pharmakopsychiatr Neuropsychopharmakol 9:220\u2013225. https:\/\/doi.org\/10.1055\/s-0028-1094495","journal-title":"Pharmakopsychiatr Neuropsychopharmakol"},{"key":"5353_CR135","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0166-4328(96)00081-2","volume":"73","author":"RJ Strassman","year":"1996","unstructured":"Strassman RJ (1996) Human psychopharmacology of N,N-dimethyltryptamine. Behav Brain Res 73:121\u2013124. https:\/\/doi.org\/10.1016\/0166-4328(96)00081-2","journal-title":"Behav Brain Res"},{"key":"5353_CR136","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/02791072.2005.10399797","volume":"37","author":"JC Callaway","year":"2005","unstructured":"Callaway JC (2005) Fast and slow metabolizers of Hoasca. J Psychoactive Drugs 37:157\u2013161. https:\/\/doi.org\/10.1080\/02791072.2005.10399797","journal-title":"J Psychoactive Drugs"},{"key":"5353_CR137","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137202","volume":"10","author":"EE Schenberg","year":"2015","unstructured":"Schenberg EE, Alexandre JFM, Filev R et al (2015) Acute biphasic effects of ayahuasca. PLoS\u00a0One 10:e0137202. https:\/\/doi.org\/10.1371\/journal.pone.0137202","journal-title":"PLoS\u00a0One"},{"key":"5353_CR138","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00541","author":"S Li","year":"2017","unstructured":"Li S, Zhang Y, Deng G et al (2017) Exposure characteristics of the analogous \u03b2-carboline alkaloids harmaline and harmine based on the efflux transporter of multidrug resistance protein 2. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2017.00541","journal-title":"Front Pharmacol"},{"key":"5353_CR139","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/1355621021000005937","volume":"7","author":"T Passie","year":"2002","unstructured":"Passie T, Seifert J, Schneider U, Emrich HM (2002) The pharmacology of psilocybin. Addict Biol 7:357\u2013364. https:\/\/doi.org\/10.1080\/1355621021000005937","journal-title":"Addict Biol"},{"key":"5353_CR140","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/00223980.1956.9916206","volume":"41","author":"HA Abramson","year":"1956","unstructured":"Abramson HA, Jarvik ME, Gorin MH, Hirsch MW (1956) Lysergic acid diethylamide (LSD-25): XVII. Tolerance development and its relationship to a theory of psychosis. J Psychol 41:81\u2013105. https:\/\/doi.org\/10.1080\/00223980.1956.9916206","journal-title":"J Psychol"},{"key":"5353_CR141","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.euroneuro.2016.03.012","volume":"26","author":"M Valle","year":"2016","unstructured":"Valle M, Maqueda AE, Rabella M et al (2016) Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans. Eur Neuropsychopharmacol 26:1161\u20131175. https:\/\/doi.org\/10.1016\/j.euroneuro.2016.03.012","journal-title":"Eur Neuropsychopharmacol"},{"key":"5353_CR142","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nature08506","volume":"462","author":"MJ Keiser","year":"2009","unstructured":"Keiser MJ, Setola V, Irwin JJ et al (2009) Predicting new molecular targets for known drugs. Nature 462:175\u2013181. https:\/\/doi.org\/10.1038\/nature08506","journal-title":"Nature"},{"key":"5353_CR143","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009019","volume":"5","author":"TS Ray","year":"2010","unstructured":"Ray TS (2010) Psychedelics and the human receptorome. PLoS\u00a0One 5:e9019. https:\/\/doi.org\/10.1371\/journal.pone.0009019","journal-title":"PLoS\u00a0One"},{"key":"5353_CR144","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0028-3908(90)90001-8","volume":"29","author":"DJ McKenna","year":"1990","unstructured":"McKenna DJ, Repke DB, Lo L, Peroutka SJ (1990) Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes. Neuropharmacology 29:193\u2013198. https:\/\/doi.org\/10.1016\/0028-3908(90)90001-8","journal-title":"Neuropharmacology"},{"key":"5353_CR145","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0014-2999(88)90432-3","volume":"145","author":"RA Lyon","year":"1988","unstructured":"Lyon RA, Titeler M, Seggel MR, Glennon RA (1988) Indolealkylamine analogs share 5-HT2 binding characteristics with phenylalkylamine hallucinogens. Eur J Pharmacol 145:291\u2013297. https:\/\/doi.org\/10.1016\/0014-2999(88)90432-3","journal-title":"Eur J Pharmacol"},{"key":"5353_CR146","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/BF00443425","volume":"97","author":"PA Pierce","year":"1989","unstructured":"Pierce PA, Peroutka SJ (1989) Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex. Psychopharmacology 97:118\u2013122. https:\/\/doi.org\/10.1007\/BF00443425","journal-title":"Psychopharmacology"},{"key":"5353_CR147","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S0893-133X(98)00135-3","volume":"21","author":"GK Aghajanian","year":"1999","unstructured":"Aghajanian GK, Marek GJ (1999) Serotonin and hallucinogens. Neuropsychopharmacology 21:16\u201323. https:\/\/doi.org\/10.1016\/S0893-133X(98)00135-3","journal-title":"Neuropsychopharmacology"},{"key":"5353_CR148","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.pharmthera.2003.11.002","volume":"101","author":"DE Nichols","year":"2004","unstructured":"Nichols DE (2004) Hallucinogens. Pharmacol Ther 101:131\u2013181. https:\/\/doi.org\/10.1016\/j.pharmthera.2003.11.002","journal-title":"Pharmacol Ther"},{"key":"5353_CR149","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0091-3057(98)00110-5","volume":"61","author":"RL Smith","year":"1998","unstructured":"Smith RL, Canton H, Barrett RJ, Sanders-Bush E (1998) Agonist properties of N, N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptors. Pharmacol Biochem Behav 61:323\u2013330. \nhttps:\/\/doi.org\/10.1016\/S0091-3057(98)00110-5","journal-title":"Pharmacol Biochem Behav"},{"key":"5353_CR150","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1007\/s00702-009-0308-8","volume":"116","author":"NV Cozzi","year":"2009","unstructured":"Cozzi NV, Gopalakrishnan A, Anderson LL et al (2009) Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter. J Neural Transm 116:1591. https:\/\/doi.org\/10.1007\/s00702-009-0308-8","journal-title":"J Neural Transm"},{"key":"5353_CR151","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.euroneuro.2015.12.039","volume":"26","author":"J Kaufman","year":"2016","unstructured":"Kaufman J, DeLorenzo C, Choudhury S, Parsey RV (2016) The 5-HT1A receptor in major depressive disorder. Eur Neuropsychopharmacol 26:397\u2013410. https:\/\/doi.org\/10.1016\/j.euroneuro.2015.12.039","journal-title":"Eur Neuropsychopharmacol"},{"key":"5353_CR152","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.pneurobio.2009.01.009","volume":"88","author":"J Savitz","year":"2009","unstructured":"Savitz J, Lucki I, Drevets WC (2009) 5-HT(1A) receptor function in major depressive disorder. Prog Neurobiol 88:17\u201331. https:\/\/doi.org\/10.1016\/j.pneurobio.2009.01.009","journal-title":"Prog Neurobiol"},{"key":"5353_CR153","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00213-013-3389-x","volume":"231","author":"AL Garcia-Garcia","year":"2014","unstructured":"Garcia-Garcia AL, Newman-Tancredi A, Leonardo ED (2014) 5-HT(1A) [corrected] receptors in mood and anxiety: recent insights into autoreceptor versus heteroreceptor function. Psychopharmacology 231:623\u2013636. https:\/\/doi.org\/10.1007\/s00213-013-3389-x","journal-title":"Psychopharmacology"},{"key":"5353_CR154","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1177\/0269881117725915","volume":"31","author":"RL Carhart-Harris","year":"2017","unstructured":"Carhart-Harris RL, Nutt DJ (2017) Serotonin and brain function: a tale of two receptors. J Psychopharmacol 31:1091\u20131120. https:\/\/doi.org\/10.1177\/0269881117725915","journal-title":"J Psychopharmacol"},{"key":"5353_CR155","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1080\/10253890.2017.1301426","volume":"20","author":"CE Stamper","year":"2017","unstructured":"Stamper CE, Hassell JE, Kapitz AJ et al (2017) Activation of 5-HT1A receptors in the rat dorsomedial hypothalamus inhibits stress-induced activation of the hypothalamic-pituitary-adrenal axis. Stress 20:223\u2013230. https:\/\/doi.org\/10.1080\/10253890.2017.1301426","journal-title":"Stress"},{"key":"5353_CR156","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/jnc.15536","volume":"162","author":"AM Jaster","year":"2022","unstructured":"Jaster AM, de la Fuente RM, Gonz\u00e1lez-Maeso J (2022) Molecular targets of psychedelic-induced plasticity. J Neurochem 162:80\u201388. https:\/\/doi.org\/10.1111\/jnc.15536","journal-title":"J Neurochem"},{"key":"5353_CR157","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.3390\/biom12111618","volume":"12","author":"GN Rossi","year":"2022","unstructured":"Rossi GN, Guerra LTL, Baker GB et al (2022) Molecular pathways of the therapeutic effects of ayahuasca, a botanical psychedelic and potential rapid-acting antidepressant. Biomolecules 12:1618. https:\/\/doi.org\/10.3390\/biom12111618","journal-title":"Biomolecules"},{"key":"5353_CR158","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/s0376-8716(97)00163-4","volume":"50","author":"B Grella","year":"1998","unstructured":"Grella B, Dukat M, Young R et al (1998) Investigation of hallucinogenic and related beta-carbolines. Drug Alcohol Depend 50:99\u2013107. https:\/\/doi.org\/10.1016\/s0376-8716(97)00163-4","journal-title":"Drug Alcohol Depend"},{"key":"5353_CR159","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.1016\/J.BMCL.2003.09.027","volume":"13","author":"B Grella","year":"2003","unstructured":"Grella B, Teitler M, Smith C et al (2003) Binding of \u03b2-Carbolines at 5-HT2  serotonin receptors. Bioorg Med Chem Lett 13:4421\u20134425. https:\/\/doi.org\/10.1016\/J.BMCL.2003.09.027","journal-title":"Bioorg Med Chem Lett"},{"key":"5353_CR160","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/syn.21643","volume":"67","author":"HD Hansen","year":"2013","unstructured":"Hansen HD, Ettrup A, Herth MM et al (2013) Direct comparison of [(18) F]MH.MZ and [(18) F] altanserin for 5-HT2A receptor imaging with PET. Synapse 67:328\u2013337. https:\/\/doi.org\/10.1002\/syn.21643","journal-title":"Synapse"},{"key":"5353_CR161","doi-asserted-by":"publisher","DOI":"10.1111\/bph.16315","author":"I Werle","year":"2024","unstructured":"Werle I, Nascimento LMM, dos Santos ALA et al (2024) Ayahuasca-enhanced extinction of fear behaviour: role of infralimbic cortex 5-HT 2A and 5-HT 1A receptors. Br J Pharmacol. https:\/\/doi.org\/10.1111\/bph.16315","journal-title":"Br J Pharmacol"},{"key":"5353_CR162","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.pnpbp.2015.12.006","volume":"66","author":"A Chagraoui","year":"2016","unstructured":"Chagraoui A, Thibaut F, Skiba M et al (2016) 5-HT2C receptors in psychiatric disorders: a review. Prog Neuropsychopharmacol Biol Psychiatry 66:120\u2013135. https:\/\/doi.org\/10.1016\/j.pnpbp.2015.12.006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"5353_CR163","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.neuint.2010.01.010","volume":"56","author":"L Minuzzi","year":"2010","unstructured":"Minuzzi L, Cumming P (2010) Agonist binding fraction of dopamine D2\/3 receptors in rat brain: a quantitative autoradiographic study. Neurochem Int 56:747\u2013752. https:\/\/doi.org\/10.1016\/j.neuint.2010.01.010","journal-title":"Neurochem Int"},{"key":"5353_CR164","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/syn.20141","volume":"56","author":"L Minuzzi","year":"2005","unstructured":"Minuzzi L, Nomikos GG, Wade MR et al (2005) Interaction between LSD and dopamine D2\/3 binding sites in pig brain. Synapse 56:198\u2013204. https:\/\/doi.org\/10.1002\/syn.20141","journal-title":"Synapse"},{"key":"5353_CR165","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2021.102599","volume":"30","author":"R Liu","year":"2021","unstructured":"Liu R, Wang Y, Chen X et al (2021) Anhedonia correlates with functional connectivity of the nucleus accumbens subregions in patients with major depressive disorder. Neuroimage Clin 30:102599. https:\/\/doi.org\/10.1016\/j.nicl.2021.102599","journal-title":"Neuroimage Clin"},{"key":"5353_CR166","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12929-021-00779-7","volume":"28","author":"RA Wise","year":"2021","unstructured":"Wise RA, Jordan CJ (2021) Dopamine, behavior, and addiction. J Biomed Sci 28:83. https:\/\/doi.org\/10.1186\/s12929-021-00779-7","journal-title":"J Biomed Sci"},{"key":"5353_CR167","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/s0376-8716(99)00148-9","volume":"60","author":"RA Glennon","year":"2000","unstructured":"Glennon RA, Dukat M, Grella B et al (2000) Binding of beta-carbolines and related agents at serotonin (5-HT(2) and 5-HT(1A)), dopamine (D(2)) and benzodiazepine receptors. Drug Alcohol Depend 60:121\u2013132. https:\/\/doi.org\/10.1016\/s0376-8716(99)00148-9","journal-title":"Drug Alcohol Depend"},{"key":"5353_CR168","doi-asserted-by":"publisher","first-page":"141","DOI":"10.4331\/wjbc.v4.i4.141","volume":"4","author":"EF de Castro-Neto","year":"2013","unstructured":"de Castro-Neto EF, da Cunha RH, da Silveira DX et al (2013) Changes in aminoacidergic and monoaminergic neurotransmission in the hippocampus and amygdala of rats after ayahuasca ingestion. World J Biol Chem 4:141\u2013147. https:\/\/doi.org\/10.4331\/wjbc.v4.i4.141","journal-title":"World J Biol Chem"},{"key":"5353_CR169","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.neuroimage.2006.11.038","volume":"35","author":"K Pedersen","year":"2007","unstructured":"Pedersen K, Simonsen M, \u00d8stergaard SD et al (2007) Mapping the  amphetamine-evoked changes in [11C]raclopride binding in living rat using small animal PET: modulation by MAO-inhibition. Neuroimage 35:38\u201346. https:\/\/doi.org\/10.1016\/j.neuroimage.2006.11.038","journal-title":"Neuroimage"},{"key":"5353_CR170","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/syn.20258","volume":"59","author":"SB Jensen","year":"2006","unstructured":"Jensen SB, Olsen AK, Pedersen K, Cumming P (2006) Effect of monoamine oxidase inhibition on amphetamine-evoked changes in dopamine receptor availability in the living pig: a dual tracer PET study with [11C]harmine and [11C]raclopride. Synapse 59:427\u2013434. https:\/\/doi.org\/10.1002\/syn.20258","journal-title":"Synapse"},{"key":"5353_CR171","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1177\/0269881112463125","volume":"27","author":"DI Brierley","year":"2013","unstructured":"Brierley DI, Davidson C (2013) Harmine augments electrically evoked dopamine efflux in the nucleus accumbens shell. J Psychopharmacol 27:98\u2013108. https:\/\/doi.org\/10.1177\/0269881112463125","journal-title":"J Psychopharmacol"},{"key":"5353_CR172","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/J.PNPBP.2012.06.001","volume":"39","author":"DI Brierley","year":"2012","unstructured":"Brierley DI, Davidson C (2012) Developments in harmine pharmacology\u2013implications for ayahuasca use and drug-dependence treatment. Prog Neuropsychopharmacol Biol Psychiatry 39:263\u2013272. https:\/\/doi.org\/10.1016\/J.PNPBP.2012.06.001","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"5353_CR173","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1080\/02791072.2012.704590","volume":"44","author":"MB Liester","year":"2012","unstructured":"Liester MB, Prickett JI (2012) Hypotheses regarding the mechanisms of ayahuasca in the treatment of addictions. J Psychoactive Drugs 44:200\u2013208. https:\/\/doi.org\/10.1080\/02791072.2012.704590","journal-title":"J Psychoactive Drugs"},{"key":"5353_CR174","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1093\/brain\/awu107","volume":"137","author":"V Francardo","year":"2014","unstructured":"Francardo V, Bez F, Wieloch T et al (2014) Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism. Brain 137:1998\u20132014. https:\/\/doi.org\/10.1093\/brain\/awu107","journal-title":"Brain"},{"key":"5353_CR175","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2021.108612","volume":"192","author":"\u00cd Szab\u00f3","year":"2021","unstructured":"Szab\u00f3 \u00cd, Varga V\u00c9, Dvor\u00e1csk\u00f3 S et al (2021) N,N-Dimethyltryptamine attenuates spreading depolarization and restrains neurodegeneration by sigma-1 receptor activation in the ischemic rat brain. Neuropharmacology 192:108612. https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108612","journal-title":"Neuropharmacology"},{"key":"5353_CR176","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1254\/jjp.85.299","volume":"85","author":"C-C Shi","year":"2001","unstructured":"Shi C-C, Liao J-F, Chen C-F (2001) Comparative study on the vasorelaxant effects of three harmala alkaloids in vitro. Jpn J Pharmacol 85:299\u2013305. https:\/\/doi.org\/10.1254\/jjp.85.299","journal-title":"Jpn J Pharmacol"},{"key":"5353_CR177","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0006-8993(95)00630-9","volume":"695","author":"M Weiss","year":"1995","unstructured":"Weiss M, Buldakova S, Dutova E (1995) Interaction of the beta-carboline harmaline with a GABA-benzodiazepine mechanism: an electrophysiological investigation on rat hippocampal slices. Brain Res 695:105\u2013109. https:\/\/doi.org\/10.1016\/0006-8993(95)00630-9","journal-title":"Brain Res"},{"key":"5353_CR178","doi-asserted-by":"publisher","first-page":"5620","DOI":"10.1021\/acsomega.9b02375","volume":"5","author":"S Jain","year":"2020","unstructured":"Jain S, Panuganti V, Jha S, Roy I (2020) Harmine acts as an indirect inhibitor of intracellular protein aggregation. ACS Omega 5:5620\u20135628. https:\/\/doi.org\/10.1021\/acsomega.9b02375","journal-title":"ACS Omega"},{"key":"5353_CR179","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s12272-020-01283-6","volume":"43","author":"L Zhang","year":"2020","unstructured":"Zhang L, Li D, Yu S (2020) Pharmacological effects of harmine and its derivatives: a review. Arch Pharm Res 43:1259\u20131275. https:\/\/doi.org\/10.1007\/s12272-020-01283-6","journal-title":"Arch Pharm Res"},{"key":"5353_CR180","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00346","author":"S-P Li","year":"2018","unstructured":"Li S-P, Wang Y-W, Qi S-L et al (2018) Analogous \u03b2-carboline alkaloids harmaline and harmine ameliorate scopolamine-induced cognition dysfunction by attenuating acetylcholinesterase activity, oxidative stress, and inflammation in mice. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2018.00346","journal-title":"Front Pharmacol"},{"key":"5353_CR181","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41401-021-00639-y","volume":"43","author":"J Huang","year":"2022","unstructured":"Huang J, Liu Y, Chen J et al (2022) Harmine is an effective therapeutic small molecule for the treatment of cardiac hypertrophy. Acta Pharmacol Sin 43:50\u201363. https:\/\/doi.org\/10.1038\/s41401-021-00639-y","journal-title":"Acta Pharmacol Sin"},{"key":"5353_CR182","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/mutage\/gem016","volume":"22","author":"DJ Moura","year":"2007","unstructured":"Moura DJ, Richter MF, Boeira JM et al (2007) Antioxidant properties of -carboline alkaloids are related to their antimutagenic and antigenotoxic activities. Mutagenesis 22:293\u2013302. https:\/\/doi.org\/10.1093\/mutage\/gem016","journal-title":"Mutagenesis"},{"key":"5353_CR183","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41386-022-01389-z","volume":"48","author":"AE Calder","year":"2023","unstructured":"Calder AE, Hasler G (2023) Towards an understanding of psychedelic-induced neuroplasticity. Neuropsychopharmacology 48:104\u2013112. https:\/\/doi.org\/10.1038\/s41386-022-01389-z","journal-title":"Neuropsychopharmacology"},{"key":"5353_CR184","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/mp.2017.144","volume":"22","author":"M Song","year":"2017","unstructured":"Song M, Martinowich K, Lee FS (2017) BDNF at the synapse: why location matters. Mol Psychiatry 22:1370\u20131375. https:\/\/doi.org\/10.1038\/mp.2017.144","journal-title":"Mol Psychiatry"},{"key":"5353_CR185","doi-asserted-by":"publisher","first-page":"7777","DOI":"10.3390\/ijms21207777","volume":"21","author":"L Colucci-D\u2019Amato","year":"2020","unstructured":"Colucci-D\u2019Amato L, Speranza L, Volpicelli F (2020) Neurotrophic factor BDNF, physiological functions and therapeutic potential in depression, neurodegeneration and brain cancer. Int J Mol Sci 21:7777. https:\/\/doi.org\/10.3390\/ijms21207777","journal-title":"Int J Mol Sci"},{"key":"5353_CR186","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.3389\/fpsyg.2019.01234","volume":"10","author":"RN de Almeida","year":"2019","unstructured":"de Almeida RN, Galv\u00e3oda Silva ACMFS et al (2019) Modulation of serum brain-derived neurotrophic factor by a single dose of ayahuasca: observation from a randomized controlled trial. Front Psychol 10:1234. https:\/\/doi.org\/10.3389\/fpsyg.2019.01234","journal-title":"Front Psychol"},{"key":"5353_CR187","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/JCP.0000000000001396","volume":"41","author":"JM Rocha","year":"2021","unstructured":"Rocha JM, Rossi GN, de Lima OF et al (2021) Effects of ayahuasca on the recognition of facial expressions of emotions in naive healthy volunteers. J Clin Psychopharmacol 41:267\u2013274. https:\/\/doi.org\/10.1097\/JCP.0000000000001396","journal-title":"J Clin Psychopharmacol"},{"key":"5353_CR188","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","volume":"23","author":"C Ly","year":"2018","unstructured":"Ly C, Greb AC, Cameron LP et al (2018) Psychedelics promote structural and functional neural plasticity. Cell Rep 23:3170\u20133182. https:\/\/doi.org\/10.1016\/j.celrep.2018.05.022","journal-title":"Cell Rep"},{"key":"5353_CR189","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1021\/acschemneuro.8b00134","volume":"9","author":"LP Cameron","year":"2018","unstructured":"Cameron LP, Benson CJ, Dunlap LE, Olson DE (2018) Effects of N,N-dimethyltryptamine on rat behaviors relevant to anxiety and depression. ACS Chem Neurosci 9:1582\u20131590. https:\/\/doi.org\/10.1021\/acschemneuro.8b00134","journal-title":"ACS Chem Neurosci"},{"key":"5353_CR190","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1126\/science.adf0435","volume":"379","author":"MV Vargas","year":"2023","unstructured":"Vargas MV, Dunlap LE, Dong C et al (2023) Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors. Science (1979) 379:700\u2013706. https:\/\/doi.org\/10.1126\/science.adf0435","journal-title":"Science (1979)"},{"key":"5353_CR191","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1021\/acschemneuro.8b00692","volume":"10","author":"LP Cameron","year":"2019","unstructured":"Cameron LP, Benson CJ, DeFelice BC et al (2019) Chronic, intermittent microdoses of the psychedelic N, N-dimethyltryptamine (DMT) produce positive effects on mood and anxiety in rodents. ACS Chem Neurosci 10:3261\u20133270. https:\/\/doi.org\/10.1021\/acschemneuro.8b00692","journal-title":"ACS Chem Neurosci"},{"key":"5353_CR192","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110208","volume":"119","author":"Z-H Zheng","year":"2023","unstructured":"Zheng Z-H, Lin X-C, Lu Y et al (2023) Harmine exerts anxiolytic effects by regulating neuroinflammation and neuronal plasticity in the basolateral amygdala. Int Immunopharmacol 119:110208. https:\/\/doi.org\/10.1016\/j.intimp.2023.110208","journal-title":"Int Immunopharmacol"},{"key":"5353_CR193","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.pnpbp.2009.07.021","volume":"33","author":"JJ Fortunato","year":"2009","unstructured":"Fortunato JJ, R\u00e9us GZ, Kirsch TR et al (2009) Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry 33:1425\u20131430. https:\/\/doi.org\/10.1016\/j.pnpbp.2009.07.021","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"5353_CR194","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41398-020-01011-0","volume":"10","author":"JA Morales-Garcia","year":"2020","unstructured":"Morales-Garcia JA, Calleja-Conde J, Lopez-Moreno JA et al (2020) N, N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivo. Transl Psychiatry 10:331. https:\/\/doi.org\/10.1038\/s41398-020-01011-0","journal-title":"Transl Psychiatry"},{"key":"5353_CR195","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1007\/s00213-020-05483-2","volume":"237","author":"BL Giacobbo","year":"2020","unstructured":"Giacobbo BL, Doorduin J, Moraga-Amaro R et al (2020) Chronic harmine treatment has a delayed effect on mobility in control and socially defeated rats. Psychopharmacology 237:1595\u20131606. https:\/\/doi.org\/10.1007\/s00213-020-05483-2","journal-title":"Psychopharmacology"},{"key":"5353_CR196","doi-asserted-by":"publisher","first-page":"5309","DOI":"10.1038\/s41598-017-05407-9","volume":"7","author":"JA Morales-Garc\u00eda","year":"2017","unstructured":"Morales-Garc\u00eda JA, de la Fuente RM, Alonso-Gil S et al (2017) The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen ayahuasca, stimulate adult neurogenesis in vitro. Sci Rep 7:5309. https:\/\/doi.org\/10.1038\/s41598-017-05407-9","journal-title":"Sci Rep"},{"key":"5353_CR197","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1242\/dev.066167","volume":"138","author":"B H\u00e4mmerle","year":"2011","unstructured":"H\u00e4mmerle B, Ulin E, Guimera J et al (2011) Transient expression of Mnb\/Dyrk1a couples cell cycle exit and differentiation of neuronal precursors by inducing p27KIP1 expression and suppressing NOTCH signaling. Development 138:2543\u20132554. https:\/\/doi.org\/10.1242\/dev.066167","journal-title":"Development"},{"key":"5353_CR198","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00213-006-0358-7","volume":"186","author":"J Riba","year":"2006","unstructured":"Riba J, Romero S, Grasa E et al (2006) Increased frontal and paralimbic activation following ayahuasca, the pan-Amazonian inebriant. Psychopharmacology 186:93\u201398. https:\/\/doi.org\/10.1007\/s00213-006-0358-7","journal-title":"Psychopharmacology"},{"key":"5353_CR199","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S0959-4388(03)00090-4","volume":"13","author":"A Craig","year":"2003","unstructured":"Craig A (2003) Interoception: the sense of the physiological condition of the body. Curr Opin Neurobiol 13:500\u2013505. https:\/\/doi.org\/10.1016\/S0959-4388(03)00090-4","journal-title":"Curr Opin Neurobiol"},{"key":"5353_CR200","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/nrn894","volume":"3","author":"AD Craig","year":"2002","unstructured":"Craig AD (2002) How do you feel? Interoception: the sense of the physiological condition of the body. Nat Rev Neurosci 3:655\u2013666. https:\/\/doi.org\/10.1038\/nrn894","journal-title":"Nat Rev Neurosci"},{"key":"5353_CR201","doi-asserted-by":"publisher","first-page":"108","DOI":"10.2174\/1570159X16666180125095902","volume":"17","author":"J Hamill","year":"2019","unstructured":"Hamill J, Hallak J, Dursun SM, Baker G (2019) Ayahuasca: psychological and physiologic effects, pharmacology and potential uses in addiction and mental illness. Curr Neuropharmacol 17:108\u2013128. https:\/\/doi.org\/10.2174\/1570159X16666180125095902","journal-title":"Curr Neuropharmacol"},{"key":"5353_CR202","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.expneurol.2013.08.017","volume":"249","author":"A Merkl","year":"2013","unstructured":"Merkl A, Schneider G-H, Sch\u00f6necker T et al (2013) Antidepressant effects after short-term and chronic stimulation of the subgenual cingulate gyrus in treatment-resistant depression. Exp Neurol 249:160\u2013168. https:\/\/doi.org\/10.1016\/j.expneurol.2013.08.017","journal-title":"Exp Neurol"},{"key":"5353_CR203","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.biopsych.2009.09.013","volume":"67","author":"BH Bewernick","year":"2010","unstructured":"Bewernick BH, Hurlemann R, Matusch A et al (2010) Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biol Psychiatry 67:110\u2013116. https:\/\/doi.org\/10.1016\/j.biopsych.2009.09.013","journal-title":"Biol Psychiatry"},{"key":"5353_CR204","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/hbm.20426","volume":"29","author":"PB Fitzgerald","year":"2008","unstructured":"Fitzgerald PB, Laird AR, Maller J, Daskalakis ZJ (2008) A meta-analytic study of changes in brain activation in depression. Hum Brain Mapp 29:683\u2013695. https:\/\/doi.org\/10.1002\/hbm.20426","journal-title":"Hum Brain Mapp"},{"key":"5353_CR205","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1176\/appi.ajp.2008.08081201","volume":"166","author":"DA Pizzagalli","year":"2009","unstructured":"Pizzagalli DA, Holmes AJ, Dillon DG et al (2009) Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. Am J Psychiatry 166:702\u2013710. https:\/\/doi.org\/10.1176\/appi.ajp.2008.08081201","journal-title":"Am J Psychiatry"},{"key":"5353_CR206","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1017\/S1092852900013754","volume":"13","author":"WC Drevets","year":"2008","unstructured":"Drevets WC, Savitz J, Trimble M (2008) The subgenual anterior cingulate cortex in mood disorders. CNS Spectr 13:663\u2013681. https:\/\/doi.org\/10.1017\/S1092852900013754","journal-title":"CNS Spectr"},{"key":"5353_CR207","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00213-008-1237-1","volume":"200","author":"J Daumann","year":"2008","unstructured":"Daumann J, Heekeren K, Neukirch A et al (2008) Pharmacological modulation of the neural basis underlying inhibition of return (IOR) in the human 5-HT2A agonist and NMDA antagonist model of psychosis. Psychopharmacology 200:573\u2013583. https:\/\/doi.org\/10.1007\/s00213-008-1237-1","journal-title":"Psychopharmacology"},{"key":"5353_CR208","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1177\/0269881109103227","volume":"24","author":"J Daumann","year":"2010","unstructured":"Daumann J, Wagner D, Heekeren K et al (2010) Neuronal correlates of visual and auditory alertness in the DMT and ketamine model of psychosis. J Psychopharmacol 24:1515\u20131524. https:\/\/doi.org\/10.1177\/0269881109103227","journal-title":"J Psychopharmacol"},{"key":"5353_CR209","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/sj.npp.1300882","volume":"31","author":"E Gouzoulis-Mayfrank","year":"2006","unstructured":"Gouzoulis-Mayfrank E, Heekeren K, Neukirch A et al (2006) Inhibition of return in the human 5HT2A agonist and NMDA antagonist model of psychosis. Neuropsychopharmacology 31:431\u2013441. https:\/\/doi.org\/10.1038\/sj.npp.1300882","journal-title":"Neuropsychopharmacology"},{"key":"5353_CR210","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1002\/HBM.21381","volume":"33","author":"DB De Araujo","year":"2012","unstructured":"De Araujo DB, Ribeiro S, Cecchi GA et al (2012) Seeing with the eyes shut: neural basis of enhanced imagery following ayahuasca ingestion. Hum Brain Mapp 33:2550\u20132560. https:\/\/doi.org\/10.1002\/HBM.21381","journal-title":"Hum Brain Mapp"},{"key":"5353_CR211","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/brain\/122.2.199","volume":"122","author":"JA Frost","year":"1999","unstructured":"Frost JA (1999) Language processing is strongly left lateralized in both sexes: evidence from functional MRI. Brain 122:199\u2013208. https:\/\/doi.org\/10.1093\/brain\/122.2.199","journal-title":"Brain"},{"key":"5353_CR212","doi-asserted-by":"publisher","first-page":"20254","DOI":"10.1073\/pnas.1112029108","volume":"108","author":"JA Brewer","year":"2011","unstructured":"Brewer JA, Worhunsky PD, Gray JR et al (2011) Meditation experience is associated with differences in default mode network activity and connectivity. Proc Natl Acad Sci USA 108:20254\u201320259. https:\/\/doi.org\/10.1073\/pnas.1112029108","journal-title":"Proc Natl Acad Sci USA"},{"key":"5353_CR213","doi-asserted-by":"publisher","first-page":"7388","DOI":"10.1038\/s41598-017-06854-0","volume":"7","author":"A Viol","year":"2017","unstructured":"Viol A, Palhano-Fontes F, Onias H et al (2017) Shannon entropy of brain functional complex networks under the influence of the psychedelic ayahuasca. Sci Rep 7:7388. https:\/\/doi.org\/10.1038\/s41598-017-06854-0","journal-title":"Sci Rep"},{"key":"5353_CR214","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fnhum.2014.00020","volume":"8","author":"RL Carhart-Harris","year":"2014","unstructured":"Carhart-Harris RL, Leech R, Hellyer PJ et al (2014) The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs. Front Hum Neurosci 8:20. https:\/\/doi.org\/10.3389\/fnhum.2014.00020","journal-title":"Front Hum Neurosci"},{"key":"5353_CR215","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/ijnp\/pyx036","volume":"20","author":"F Sampedro","year":"2017","unstructured":"Sampedro F, de la Fuente RM, Valle M et al (2017) Assessing the psychedelic \u201cafter-glow\u201d in ayahuasca users: post-acute neurometabolic and functional connectivity changes are associated with enhanced mindfulness capacities. Int J Neuropsychopharmacol 20:698\u2013711. https:\/\/doi.org\/10.1093\/ijnp\/pyx036","journal-title":"Int J Neuropsychopharmacol"},{"key":"5353_CR216","doi-asserted-by":"publisher","first-page":"4853","DOI":"10.1073\/pnas.1518377113","volume":"113","author":"RL Carhart-Harris","year":"2016","unstructured":"Carhart-Harris RL, Muthukumaraswamy S, Roseman L et al (2016) Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proc Natl Acad Sci 113:4853\u20134858. https:\/\/doi.org\/10.1073\/pnas.1518377113","journal-title":"Proc Natl Acad Sci"},{"key":"5353_CR217","doi-asserted-by":"publisher","first-page":"10544","DOI":"10.1523\/JNEUROSCI.3007-12.2013","volume":"33","author":"M Kometer","year":"2013","unstructured":"Kometer M, Schmidt A, Jancke L,  Vollenweider FX (2013) Activation of serotonin 2A receptors underlies the psilocybin-induced effects on oscillations, N170 visual-evoked potentials, and visual hallucinations. J Neurosci 33:10544\u201310551. https:\/\/doi.org\/10.1523\/JNEUROSCI.3007-12.2013","journal-title":"J Neurosci"},{"key":"5353_CR218","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1159\/000361078","volume":"83","author":"CG Abdallah","year":"2014","unstructured":"Abdallah CG, Niciu MJ, Fenton LR et al (2014) Decreased occipital cortical glutamate levels in response to successful cognitive-behavioral therapy and pharmacotherapy for major depressive disorder. Psychother Psychosom 83:298\u2013307. https:\/\/doi.org\/10.1159\/000361078","journal-title":"Psychother Psychosom"},{"key":"5353_CR219","doi-asserted-by":"publisher","first-page":"9673","DOI":"10.1073\/pnas.0504136102","volume":"102","author":"MD Fox","year":"2005","unstructured":"Fox MD, Snyder AZ, Vincent JL et al (2005) The human brain is intrinsically organized into dynamic, anticorrelated functional networks. Proc Natl Acad Sci 102:9673\u20139678. https:\/\/doi.org\/10.1073\/pnas.0504136102","journal-title":"Proc Natl Acad Sci"},{"key":"5353_CR220","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1093\/schbul\/sbs117","volume":"39","author":"RL Carhart-Harris","year":"2013","unstructured":"Carhart-Harris RL, Leech R, Erritzoe D et al (2013) Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis. Schizophr Bull 39:1343\u20131351. https:\/\/doi.org\/10.1093\/schbul\/sbs117","journal-title":"Schizophr Bull"},{"key":"5353_CR221","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1177\/0269881120909409","volume":"34","author":"L Pasquini","year":"2020","unstructured":"Pasquini L, Palhano-Fontes F, Araujo DB (2020) Subacute effects of the psychedelic ayahuasca on the salience and default mode networks. J Psychopharmacol 34:623\u2013635. https:\/\/doi.org\/10.1177\/0269881120909409","journal-title":"J Psychopharmacol"},{"key":"5353_CR222","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2023.120480","volume":"285","author":"P Mallaroni","year":"2024","unstructured":"Mallaroni P, Mason NL, Kloft L et al (2024) Shared functional connectome fingerprints following ritualistic ayahuasca intake. Neuroimage 285:120480. https:\/\/doi.org\/10.1016\/j.neuroimage.2023.120480","journal-title":"Neuroimage"},{"key":"5353_CR223","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1152\/jn.00338.2011","volume":"106","author":"BTT Yeo","year":"2011","unstructured":"Yeo BTT, Krienen FM, Sepulcre J et al (2011) The organization of the human cerebral cortex estimated by intrinsic functional connectivity. J Neurophysiol 106:1125\u20131165. https:\/\/doi.org\/10.1152\/jn.00338.2011","journal-title":"J Neurophysiol"},{"key":"5353_CR224","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2218949120","author":"C Timmermann","year":"2023","unstructured":"Timmermann C, Roseman L, Haridas S et al (2023) Human brain effects of DMT assessed via EEG-fMRI. Proc Natl Acad Sci. https:\/\/doi.org\/10.1073\/pnas.2218949120","journal-title":"Proc Natl Acad Sci"},{"key":"5353_CR225","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.tics.2017.11.002","volume":"22","author":"JM Huntenburg","year":"2018","unstructured":"Huntenburg JM, Bazin P-L, Margulies DS (2018) Large-scale gradients in human cortical organization. Trends Cogn Sci 22:21\u201331. https:\/\/doi.org\/10.1016\/j.tics.2017.11.002","journal-title":"Trends Cogn Sci"},{"key":"5353_CR226","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117430","volume":"320","author":"T Arruda Sanchez","year":"2024","unstructured":"Arruda Sanchez T, Ramos LR, Araujo F et al (2024) Emotion regulation effects of ayahuasca in experienced subjects during implicit aversive stimulation: an fMRI study. J Ethnopharmacol 320:117430. https:\/\/doi.org\/10.1016\/j.jep.2023.117430","journal-title":"J Ethnopharmacol"},{"key":"5353_CR227","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0944-7113(98)80003-2","volume":"5","author":"NS Don","year":"1998","unstructured":"Don NS, McDonough BE, Moura G et al (1998) Effects of ayahuasca on the human EEG. Phytomedicine 5:87\u201396. https:\/\/doi.org\/10.1016\/S0944-7113(98)80003-2","journal-title":"Phytomedicine"},{"key":"5353_CR228","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1046\/j.1365-2125.2002.01609.x","volume":"53","author":"J Riba","year":"2002","unstructured":"Riba J, Anderer P, Morte A et al (2002) Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers. Br J Clin Pharmacol 53:613\u2013628. https:\/\/doi.org\/10.1046\/j.1365-2125.2002.01609.x","journal-title":"Br J Clin Pharmacol"},{"key":"5353_CR229","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000077946","volume":"50","author":"J Riba","year":"2004","unstructured":"Riba J, Anderer P, Jan\u00e9 F et al (2004) Effects of the south american psychoactive beverage ayahuasca on regional brain electrical activity in humans: a functional neuroimaging study using low-resolution electromagnetic tomography. Neuropsychobiology 50:89\u2013101. https:\/\/doi.org\/10.1159\/000077946","journal-title":"Neuropsychobiology"},{"key":"5353_CR230","first-page":"291","volume":"15","author":"B Saletu","year":"1993","unstructured":"Saletu B, Barbanoj MJ, Anderer P et al (1993) Clinical-pharmacological study with the two isomers (d-, l-) of fenfluramine and its comparison with chlorpromazine and d-amphetamine: blood levels, EEG mapping and safety evaluation. Methods Find Exp Clin Pharmacol 15:291\u2013312","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"5353_CR231","first-page":"385","volume-title":"Clinical applications of computer analysis of EEG and other neurophysiological signals","author":"W Herrmann","year":"1986","unstructured":"Herrmann W (1986) Pharmaco-EEG: computer EEG analysis to describe the projection of drug effects on a functional cerebral level in humans. In: Lopes da Silva FH, Storm van Leeuwen W, R\u00e9mond A (eds) Clinical applications of computer analysis of EEG and other neurophysiological signals. Elsevier, Amsterdam, pp 385\u2013448"},{"key":"5353_CR232","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0091-3057(02)00845-6","volume":"73","author":"A K\u0142odzinska","year":"2002","unstructured":"K\u0142odzinska A, Bijak M, Tokarski K, Pilc A (2002) Group II mGlu receptor agonists inhibit behavioural and electrophysiological effects of DOI in mice. Pharmacol Biochem Behav 73:327\u2013332. https:\/\/doi.org\/10.1016\/S0091-3057(02)00845-6","journal-title":"Pharmacol Biochem Behav"},{"key":"5353_CR233","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyv039","author":"JF Alonso","year":"2015","unstructured":"Alonso JF, Romero S, Ma\u00f1anas M\u00c0, Riba J (2015) Serotonergic psychedelics temporarily modify information transfer in humans. Int J Neuropsychopharmacol. https:\/\/doi.org\/10.1093\/ijnp\/pyv039","journal-title":"Int J Neuropsychopharmacol"},{"key":"5353_CR234","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00213-008-1129-4","volume":"199","author":"K Heekeren","year":"2008","unstructured":"Heekeren K, Daumann J, Neukirch A et al (2008) Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis. Psychopharmacology 199:77\u201388. https:\/\/doi.org\/10.1007\/s00213-008-1129-4","journal-title":"Psychopharmacology"},{"key":"5353_CR235","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/1469-8986.3720190","volume":"37","author":"EK Vogel","year":"2000","unstructured":"Vogel EK, Luck SJ (2000) The visual N1 component as an index of a discrimination process. Psychophysiology 37:190\u2013203","journal-title":"Psychophysiology"},{"key":"5353_CR236","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/sj.npp.1300005","volume":"28","author":"D Umbricht","year":"2003","unstructured":"Umbricht D, Vollenweider FX, Schmid L et al (2003) Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia. Neuropsychopharmacology 28:170\u2013181. https:\/\/doi.org\/10.1038\/sj.npp.1300005","journal-title":"Neuropsychopharmacology"},{"key":"5353_CR237","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/S0006-3223(02)01642-6","volume":"53","author":"D Umbricht","year":"2003","unstructured":"Umbricht D, Koller R, Schmid L et al (2003) How specific are deficits in mismatch negativity generation to schizophrenia? Biol Psychiatry 53:1120\u20131131. https:\/\/doi.org\/10.1016\/S0006-3223(02)01642-6","journal-title":"Biol Psychiatry"},{"key":"5353_CR238","doi-asserted-by":"publisher","first-page":"16324","DOI":"10.1038\/s41598-019-51974-4","volume":"9","author":"C Timmermann","year":"2019","unstructured":"Timmermann C, Roseman L, Schartner M et al (2019) Neural correlates of the DMT experience assessed with multivariate EEG. Sci Rep 9:16324. https:\/\/doi.org\/10.1038\/s41598-019-51974-4","journal-title":"Sci Rep"},{"key":"5353_CR239","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.59784","author":"A Alamia","year":"2020","unstructured":"Alamia A, Timmermann C, Nutt DJ et al (2020) DMT alters cortical travelling waves. Elife. https:\/\/doi.org\/10.7554\/eLife.59784","journal-title":"Elife"},{"key":"5353_CR240","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000487","volume":"17","author":"A Alamia","year":"2019","unstructured":"Alamia A, VanRullen R (2019) Alpha oscillations and traveling waves: signatures of predictive coding? PLoS Biol 17:e3000487. https:\/\/doi.org\/10.1371\/journal.pbio.3000487","journal-title":"PLoS Biol"},{"key":"5353_CR241","doi-asserted-by":"publisher","DOI":"10.1093\/NC\/NIAA024","author":"MM Schartner","year":"2020","unstructured":"Schartner MM, Timmermann C (2020) Neural network models for DMT-induced visual hallucinations. Neurosci Conscious. https:\/\/doi.org\/10.1093\/NC\/NIAA024","journal-title":"Neurosci Conscious"},{"key":"5353_CR242","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1177\/0269881120981384","volume":"35","author":"C Pallavicini","year":"2021","unstructured":"Pallavicini C, Cavanna F, Zamberlan F et al (2021) Neural and subjective effects of inhaled N, N-dimethyltryptamine in natural settings. J Psychopharmacol 35:406\u2013420. https:\/\/doi.org\/10.1177\/0269881120981384","journal-title":"J Psychopharmacol"},{"key":"5353_CR243","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.720066","author":"E Tagliazucchi","year":"2021","unstructured":"Tagliazucchi E, Zamberlan F, Cavanna F et al (2021) Baseline power of theta oscillations predicts mystical-type experiences induced by DMT in a natural setting. Front Psychiatry. https:\/\/doi.org\/10.3389\/fpsyt.2021.720066","journal-title":"Front Psychiatry"},{"key":"5353_CR244","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S1053-8119(03)00344-6","volume":"20","author":"M Moosmann","year":"2003","unstructured":"Moosmann M, Ritter P, Krastel I et al (2003) Correlates of alpha rhythm in functional magnetic resonance imaging and near infrared spectroscopy. Neuroimage 20:145\u2013158. https:\/\/doi.org\/10.1016\/S1053-8119(03)00344-6","journal-title":"Neuroimage"},{"key":"5353_CR245","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0079-6123(08)62182-2","volume":"62","author":"MS Buchsbaum","year":"1984","unstructured":"Buchsbaum MS, Kessler R, King A et al (1984) Simultaneous cerebral glucography with positron emission tomography and topographic electroencephalography. Prog Brain Res 62:263\u2013269. https:\/\/doi.org\/10.1016\/S0079-6123(08)62182-2","journal-title":"Prog Brain Res"},{"key":"5353_CR246","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.neuroimage.2007.01.022","volume":"35","author":"JC de Munck","year":"2007","unstructured":"de Munck JC, Gon\u00e7alves SI, Huijboom L et al (2007) The hemodynamic response of the alpha rhythm: an EEG\/fMRI study. Neuroimage 35:1142\u20131151. https:\/\/doi.org\/10.1016\/j.neuroimage.2007.01.022","journal-title":"Neuroimage"},{"key":"5353_CR247","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ijpsycho.2008.07.018","volume":"71","author":"E Ba\u015far","year":"2009","unstructured":"Ba\u015far E, G\u00fcntekin B (2009) Darwin\u2019s evolution theory, brain oscillations, and complex brain function in a new \u201cCartesian view.\u201d Int J Psychophysiol 71:2\u20138. https:\/\/doi.org\/10.1016\/j.ijpsycho.2008.07.018","journal-title":"Int J Psychophysiol"},{"key":"5353_CR248","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.tics.2012.10.007","volume":"16","author":"W Klimesch","year":"2012","unstructured":"Klimesch W (2012) Alpha-band oscillations, attention, and controlled access to stored information. Trends Cogn Sci 16:606\u2013617. https:\/\/doi.org\/10.1016\/j.tics.2012.10.007","journal-title":"Trends Cogn Sci"},{"key":"5353_CR249","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s004220050360","volume":"76","author":"E Ba\u015far","year":"1997","unstructured":"Ba\u015far E, Yordanova J, Kolev V, Ba\u015far-Eroglu C (1997) Is the alpha rhythm a control parameter for brain responses? Biol Cybern 76:471\u2013480. https:\/\/doi.org\/10.1007\/s004220050360","journal-title":"Biol Cybern"},{"key":"5353_CR250","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1093\/cercor\/bhv146","volume":"26","author":"A Mayer","year":"2016","unstructured":"Mayer A, Schwiedrzik CM, Wibral M et al (2016) Expecting to see a letter: alpha oscillations as carriers of top-down sensory predictions. Cereb Cortex 26:3146\u20133160. https:\/\/doi.org\/10.1093\/cercor\/bhv146","journal-title":"Cereb Cortex"},{"key":"5353_CR251","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1162\/jocn_a_01190","volume":"30","author":"L Wang","year":"2018","unstructured":"Wang L, Hagoort P, Jensen O (2018) Language prediction is reflected by coupling between frontal gamma and posterior alpha oscillations. J Cogn Neurosci 30:432\u2013447. https:\/\/doi.org\/10.1162\/jocn_a_01190","journal-title":"J Cogn Neurosci"},{"key":"5353_CR252","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1124\/pr.118.017160","volume":"71","author":"RL Carhart-Harris","year":"2019","unstructured":"Carhart-Harris RL, Friston KJ (2019) REBUS and the anarchic brain: toward a unified model of the brain action of psychedelics. Pharmacol Rev 71:316\u2013344. https:\/\/doi.org\/10.1124\/pr.118.017160","journal-title":"Pharmacol Rev"},{"key":"5353_CR253","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41583-020-0367-2","volume":"21","author":"FX Vollenweider","year":"2020","unstructured":"Vollenweider FX, Preller KH (2020) Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders. Nat Rev Neurosci 21:611\u2013624. https:\/\/doi.org\/10.1038\/s41583-020-0367-2","journal-title":"Nat Rev Neurosci"},{"key":"5353_CR254","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/s0361-9230(01)00646-3","volume":"56","author":"FX Vollenweider","year":"2001","unstructured":"Vollenweider FX, Geyer MA (2001) A systems model of altered consciousness: integrating natural and drug-induced psychoses. Brain Res Bull 56:495\u2013507. https:\/\/doi.org\/10.1016\/s0361-9230(01)00646-3","journal-title":"Brain Res Bull"},{"key":"5353_CR255","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.tics.2018.12.001","volume":"23","author":"PR Corlett","year":"2019","unstructured":"Corlett PR, Horga G, Fletcher PC et al (2019) Hallucinations and strong priors. Trends Cogn Sci 23:114\u2013127. https:\/\/doi.org\/10.1016\/j.tics.2018.12.001","journal-title":"Trends Cogn Sci"},{"key":"5353_CR256","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/brain\/awab406","volume":"145","author":"MK Doss","year":"2022","unstructured":"Doss MK, Madden MB, Gaddis A et al (2022) Models of psychedelic drug action: modulation of cortical-subcortical circuits. Brain 145:441\u2013456. https:\/\/doi.org\/10.1093\/brain\/awab406","journal-title":"Brain"},{"key":"5353_CR257","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s44220-023-00172-3","volume":"2","author":"D Erritzoe","year":"2024","unstructured":"Erritzoe D, Timmermann C, Godfrey K et al (2024) Exploring mechanisms of psychedelic action using neuroimaging. Nat Mental Health 2:141\u2013153. https:\/\/doi.org\/10.1038\/s44220-023-00172-3","journal-title":"Nat Mental Health"},{"key":"5353_CR258","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-022-01177-4","author":"AC Kwan","year":"2022","unstructured":"Kwan AC, Olson DE, Preller KH, Roth BL (2022) The neural basis of psychedelic action. Nat Neurosci. https:\/\/doi.org\/10.1038\/s41593-022-01177-4","journal-title":"Nat Neurosci"},{"key":"5353_CR259","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/ijnp\/pyac074","volume":"26","author":"JJ Gattuso","year":"2023","unstructured":"Gattuso JJ, Perkins D, Ruffell S et al (2023) Default mode network modulation by psychedelics: a systematic review. Int J Neuropsychopharmacol 26:155\u2013188. https:\/\/doi.org\/10.1093\/ijnp\/pyac074","journal-title":"Int J Neuropsychopharmacol"},{"key":"5353_CR260","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2022.104689","volume":"138","author":"DE-W McCulloch","year":"2022","unstructured":"McCulloch DE-W, Knudsen GM, Barrett FS et al (2022) Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analyses. Neurosci Biobehav Rev 138:104689. https:\/\/doi.org\/10.1016\/j.neubiorev.2022.104689","journal-title":"Neurosci Biobehav Rev"},{"key":"5353_CR261","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042421","volume":"7","author":"JC Bouso","year":"2012","unstructured":"Bouso JC, Gonz\u00e1lez D, Fondevila S et al (2012) Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of ayahuasca: a longitudinal study. PLoS\u00a0One 7:e42421. https:\/\/doi.org\/10.1371\/journal.pone.0042421","journal-title":"PLoS\u00a0One"},{"key":"5353_CR262","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/0022167888284002","volume":"28","author":"DN Elkins","year":"1988","unstructured":"Elkins DN, Hedstrom LJ, Hughes LL et al (1988) Toward a humanistic-phenomenological spirituality. J Humanist Psychol 28:5\u201318. https:\/\/doi.org\/10.1177\/0022167888284002","journal-title":"J Humanist Psychol"},{"key":"5353_CR263","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.euroneuro.2015.01.008","volume":"25","author":"JC Bouso","year":"2015","unstructured":"Bouso JC, Palhano-Fontes F, Rodriguez-Fornells A et al (2015) Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans. Eur Neuropsychopharmacol 25:483\u2013492. https:\/\/doi.org\/10.1016\/j.euroneuro.2015.01.008","journal-title":"Eur Neuropsychopharmacol"},{"key":"5353_CR264","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.1002455","author":"O Simonsson","year":"2022","unstructured":"Simonsson O, Bouso JC, Kurth F et al (2022) Preliminary evidence of links between ayahuasca use and the corpus callosum. Front Psychiatry. https:\/\/doi.org\/10.3389\/fpsyt.2022.1002455","journal-title":"Front Psychiatry"},{"key":"5353_CR265","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/ana.410430314","volume":"43","author":"B Meyer","year":"1998","unstructured":"Meyer B, R\u00f6richt S, Woiciechowsky C (1998) Topography of fibers in the human corpus callosum mediating interhemispheric inhibition between the motor cortices. Ann Neurol 43:360\u2013369. https:\/\/doi.org\/10.1002\/ana.410430314","journal-title":"Ann Neurol"},{"key":"5353_CR266","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2017.00068","author":"D Petrov","year":"2017","unstructured":"Petrov D, Mansfield C, Moussy A, Hermine O (2017) ALS clinical trials review: 20 years of failure. Are we any closer to registering a new treatment? Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2017.00068","journal-title":"Front Aging Neurosci"},{"key":"5353_CR267","doi-asserted-by":"publisher","first-page":"3358","DOI":"10.1038\/s41467-020-17051-5","volume":"11","author":"J Seidlitz","year":"2020","unstructured":"Seidlitz J, Nadig A, Liu S et al (2020) Transcriptomic and cellular decoding of regional brain vulnerability to neurogenetic disorders. Nat Commun 11:3358. https:\/\/doi.org\/10.1038\/s41467-020-17051-5","journal-title":"Nat Commun"},{"key":"5353_CR268","doi-asserted-by":"publisher","first-page":"1217079","DOI":"10.3389\/fnins.2023.1217079","volume":"17","author":"P Mallaroni","year":"2023","unstructured":"Mallaroni P, Mason NL, Kloft L et al (2023) Cortical structural differences following repeated ayahuasca use hold molecular signatures. Front Neurosci 17:1217079. https:\/\/doi.org\/10.3389\/fnins.2023.1217079","journal-title":"Front Neurosci"},{"key":"5353_CR269","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1124\/jpet.114.219337","volume":"351","author":"DA Smith","year":"2014","unstructured":"Smith DA, Bailey JM, Williams D, Fantegrossi WE (2014) Tolerance and cross-tolerance to head twitch behavior elicited by phenethylamine- and tryptamine-derived hallucinogens in mice. J Pharmacol Exp Ther 351:485\u2013491. https:\/\/doi.org\/10.1124\/jpet.114.219337","journal-title":"J Pharmacol Exp Ther"},{"key":"5353_CR270","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00213-013-3167-9","volume":"230","author":"JC Bouso","year":"2013","unstructured":"Bouso JC, F\u00e1bregas JM, Antonijoan RM et al (2013) Acute effects of ayahuasca on neuropsychological performance: differences in executive function between experienced and occasional users. Psychopharmacology 230:415\u2013424. https:\/\/doi.org\/10.1007\/s00213-013-3167-9","journal-title":"Psychopharmacology"},{"key":"5353_CR271","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1001\/jamapsychiatry.2013.3067","volume":"71","author":"L Miller","year":"2014","unstructured":"Miller L, Bansal R, Wickramaratne P et al (2014) Neuroanatomical correlates of religiosity and spirituality: a study in adults at high and low familial risk for depression. JAMA Psychiat 71:128\u2013135. https:\/\/doi.org\/10.1001\/jamapsychiatry.2013.3067","journal-title":"JAMA Psychiat"},{"key":"5353_CR272","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1038\/s41380-023-02271-0","volume":"28","author":"MB Wall","year":"2023","unstructured":"Wall MB, Harding R, Zafar R et al (2023) Neuroimaging in psychedelic drug development: past, present, and future. Mol Psychiatry 28:3573\u20133580. https:\/\/doi.org\/10.1038\/s41380-023-02271-0","journal-title":"Mol Psychiatry"},{"key":"5353_CR273","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2016.44","volume":"3","author":"KJ Gorgolewski","year":"2016","unstructured":"Gorgolewski KJ, Auer T, Calhoun VD et al (2016) The brain imaging data structure, a format for organizing and describing outputs of neuroimaging experiments. Sci Data 3:160044. https:\/\/doi.org\/10.1038\/sdata.2016.44","journal-title":"Sci Data"},{"key":"5353_CR274","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41592-018-0235-4","volume":"16","author":"O Esteban","year":"2019","unstructured":"Esteban O, Markiewicz CJ, Blair RW et al (2019) fMRIPrep: a robust preprocessing pipeline for functional MRI. Nat Methods 16:111\u2013116. https:\/\/doi.org\/10.1038\/s41592-018-0235-4","journal-title":"Nat Methods"},{"key":"5353_CR275","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22020835","author":"NR Raval","year":"2021","unstructured":"Raval NR, Johansen A, Donovan LL et al (2021) A single dose of psilocybin increases synaptic density and decreases 5-HT2A receptor density in the pig brain. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22020835","journal-title":"Int J Mol Sci"},{"key":"5353_CR276","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.1021\/acschemneuro.9b00528","volume":"11","author":"CBM Poulie","year":"2020","unstructured":"Poulie CBM, Jensen AA, Halberstadt AL, Kristensen JL (2020) DARK classics in chemical neuroscience: NBOMes. ACS Chem Neurosci 11:3860\u20133869. https:\/\/doi.org\/10.1021\/acschemneuro.9b00528","journal-title":"ACS Chem Neurosci"},{"key":"5353_CR277","unstructured":"Heim R (2004) Synthese und Pharmakologie potenter 5-HT2A-Rezeptoragonisten mit N-2-Methoxybenzyl-Partialstruktur: Entwicklung eines neuen Struktur-Wirkungskonzepts. Doctoral Dissertation, Freie Universit\u00e4t Berlin"},{"key":"5353_CR278","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1097\/00004647-200205000-00011","volume":"22","author":"P Cumming","year":"2002","unstructured":"Cumming P, Wong DF, Gillings N et al (2002) Specific binding of [(11)C]raclopride and N-[(3)H]propyl-norapomorphine to dopamine receptors in living mouse striatum: occupancy by endogenous dopamine and guanosine triphosphate-free G protein. J Cereb Blood Flow Metab 22:596\u2013604. https:\/\/doi.org\/10.1097\/00004647-200205000-00011","journal-title":"J Cereb Blood Flow Metab"},{"key":"5353_CR279","first-page":"1414","volume":"46","author":"JS Fowler","year":"2005","unstructured":"Fowler JS, Logan J, Wang G-J et al (2005) Comparison of monoamine oxidase a in peripheral organs in nonsmokers and smokers. J Nucl Med 46:1414\u20131420","journal-title":"J Nucl Med"},{"key":"5353_CR280","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1080\/02791072.2002.10399963","volume":"34","author":"R Rodd","year":"2002","unstructured":"Rodd R (2002) Snuff synergy: preparation, use and pharmacology of Yopo and Banisteriopsis Caapi among the piaroa of southern Venezuela. J Psychoactive Drugs 34:273\u2013279. https:\/\/doi.org\/10.1080\/02791072.2002.10399963","journal-title":"J Psychoactive Drugs"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-024-05353-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-024-05353-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-024-05353-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T14:06:22Z","timestamp":1725977182000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-024-05353-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,10]]},"references-count":280,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["5353"],"URL":"https:\/\/doi.org\/10.1007\/s00018-024-05353-6","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,10]]},"assertion":[{"value":"16 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MS co-founded Reconnect Labs, an academic spin-off at the University of Zurich. KE, HDA and PC have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"395"}}